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Novelty and Impact 
The study identified 56 circulating proteins, for which their genetically predicted levels were 
associated with breast cancer risk. These proteins are involved in estrogen receptor signaling, 
insulin resistance, and other important biological processes, and may serve as candidate 

















A small number of circulating proteins have been reported to be associated with breast cancer 
risk, with inconsistent results. Herein, we attempted to identify novel protein biomarkers for 
breast cancer via the integration of genomics and proteomics data. In the Breast Cancer 
Association Consortium (BCAC), with 122,977 cases and 105,974 controls of European 
descendants, we evaluated the associations of the genetically predicted concentrations of >1,400 
circulating proteins with breast cancer risk. We used data from a large-scale protein quantitative 
trait loci (pQTL) analysis as our study instrument. Summary statistics for these pQTL variants 
related to breast cancer risk were obtained from the BCAC and used to estimate odds ratios (OR) 
for each protein using the inverse-variance weighted method. We identified 56 proteins 
significantly associated with breast cancer risk by instrumental analysis (false discovery rate < 
0.05). Of these, the concentrations of 32 were influenced by variants close to a breast cancer 
susceptibility locus (ABO, 9q34.2). Many of these proteins, such as insulin receptor, insulin-like 





), are linked to insulin resistance and estrogen receptor signaling pathways. Proteins 
identified at other loci include those involved in biological processes such as alcohol and lipid 
metabolism, proteolysis, apoptosis, immune regulation, and cell motility and proliferation. 
Consistent associations were observed for 22 proteins in the UK Biobank data (P < 0.05). The 
study identifies potential novel biomarkers for breast cancer, but further investigation is needed 






 Breast cancer is the most common malignancy diagnosed among women in many 
countries 
1
. Established risk factors for breast cancer include certain menstrual and reproductive 
factors, postmenopausal obesity, the use of hormone replacement therapy, family history of the 
disease, and the carrying of high-penetrance mutations 
2, 3
. Circulating protein biomarkers have 
an important utility in cancer screening and risk assessment 
4
. Several circulating protein 
biomarkers of breast cancer risk have been reported in observational studies. Some examples of 
these are C-reactive proteins (CRP), insulin-like growth factor 1 (IGF1), and leptin 
5-8
. However, 
conventional observational studies may be influenced by reverse causation, confounding, 
selection biases, or small sample sizes. Therefore, results from previous studies have been 
inconsistent.  
 There is compelling evidence that the concentration of many circulating proteins may be 
determined by genetic variants 
9, 10
. A twin study measured 342 proteins in plasma and estimated 
that the mean heritability was ~14% 
11
. Since genetic alleles are randomly distributed during 
gamete formation, the variations in protein concentration determined by genetic variants should 
not be affected by environmental exposures or lifestyle factors. Therefore, the use of genetic 
variants as instruments to investigate circulating proteins in relation to cancer risk can reduce 
confounding effects, selection biases, and circumvent reverse causation, all of which are 
frequently encountered in epidemiological studies 
12
. Importantly, the genetically determined 
protein concentrations represent a long-term exposure since birth. Recently, Sun et al. identified 
1,927 genome-wide significant protein quantitative trait loci (pQTL) in individuals of European 
ancestry 
10
. Herein, we have utilized these pQTL variants as instruments to evaluate the 
genetically predicted concentration of each of the 1,469 proteins in relation to breast cancer risk 
8 
 
in the Breast Cancer Association Consortium (BCAC). The identified associations were further 
assessed using UK Biobank data.  
  
Material and Methods  
 An inverse-variance weighted method 
13
 was used to evaluate the associations of 
predicted circulating protein concentrations with breast cancer risk using summary statistics data 
from two sources. The first was beta coefficients of the associations between genetic variants and 
circulating protein concentrations. These were obtained from a recent genome-wide association 
study (GWAS) to identify protein quantitative trait loci (pQTL) that evaluated 2,994 circulating 
proteins in 3,301 healthy subjects of European descent 
10
. The proteins were quantified using 
SOMAscan platform. A total of 1,927 associations were identified for 1,478 circulating proteins 
with a P < 1.5×10
-11
. The second source of summary statistics for each of these pQTL variants 
came from the GWAS of breast cancer risk in the BCAC studies that comprised three datasets: 
11 individual breast cancer GWAS combined (14,910 cases and 17,588 controls), the 
Collaborative Oncological Gene-environment Study (iCOGS) (46,785 cases and 42,892 
controls), and the OncoArray study (61,282 cases and 45,494 controls) 
14-16
. Summary statistics 
of iCOGS and OncoArray can be accessed through the BCAC website 
(http://bcac.ccge.medschl.cam.ac.uk/bcacdata/). All participating studies of the BCAC were 
approved by their corresponding ethics review boards and all subjects provided informed 
consent. Our analyses were limited to the women of European ancestry included in the BCAC. 
Details of the genotyping protocols in the BCAC have been published elsewhere 
15-17
 (iCOGS: 
http://ccge.medschl.cam.ac.uk/research/consortia/icogs/). Samples included in the OncoArray, 
9 
 
iCOGS, and nine of the individual GWAS datasets were imputed by IMPUTE version 2, using 
the 1000 Genomes Project (October 2014 version 3 release) dataset as the reference panel 
16, 18
. 




 Approximately 25% of the instruments were constructed using multiple genetic variants. 
When multiple variants were associated with a single protein, only those with linkage 
disequilibrium (LD) < 0.1 were retained for downstream analyses. The F-statistic was used to 
measure the strength of the instruments, with 10 being a commonly used threshold 
21
. It was 
calculated following the formula R2*(n-1-k)/(1-R2)/k, where R2 is percentage of variance 
explained by used SNPs; n is the sample size of BCAC data (=228,951); and k is the number of 
SNPs used in the instrument. Thanks to the large sample size of the BCAC, all of the instruments 
have an F-statistic of > 1,000. The beta coefficient of the association between genetically 





−2 ) and its standard error calculated as 1/(∑ 𝛽𝑖,𝐺𝑋
2
𝑖 ∗ 𝜎𝑖,𝐺𝑌
−2 )0.5, where 
βi,GX is the beta coefficient of the association between i th SNP and the protein of interest from 
the above-mentioned pQTL study 
10
. GY represents the association between i th SNP and breast 
cancer risk in the BCAC meta-analysis [overall, estrogen receptor-positive (ER+), or ER-
negative (ER-)]; thus, βi,GY and σi,GY are the corresponding beta coefficient and standard error for 
SNPi, respectively. Odds ratio (OR) was expressed as the exponential of beta coefficients. The 
Benjamini-Hochberg false discovery rate (FDR) of < 0.05 was used as the significance level for 
a two-sided test. The ingenuity pathway analysis was employed to visualize the potential 
interplay of genes and proteins.  
10 
 
 We downloaded genetic association summary statistics for each identified risk-associated 
protein from http://www.phpc.cam.ac.uk/ceu/proteins. We abstracted pQTL variants associated 




 < 0.1) to construct new instruments, then performed sensitivity 
analyses.  
 Summary statistics derived from the associations between genetic variants and breast 
cancer risk using the UK Biobank samples were obtained to replicate the associations revealed in 
the BCAC 
22
. The imputation was completed by combining the Haplotype Reference Consortium 
and the UK10K haplotype resource as the reference panel. Genome-wide association analyses 
for over 2,000 phenotypes were conducted using data from ~337,000 unrelated individuals of 
British ancestry included in the UK Biobank 
(https://sites.google.com/broadinstitute.org/ukbbgwasresults/home?authuser=0). The statistics 
for the associations of SNPs with breast cancer risk were used for our validation study. A highly 
correlated proxy SNP (R
2 
> 0.9) was identified and used to construct the genetic instrument if the 
original SNP was not available (e.g. if insertions/deletions or variants failed in the quality control 
assessment). Since the majority of the 2,000 phenotypes were in continuous form, a linear 
regression model was employed for all phenotypes, including binary outcomes. We obtained 
summary statistics data derived from the analysis conducted for histologically-confirmed 
incident breast cancers (ICD-10: C50, N = 5,510) and prevalent breast cancers reported by 
participants at the baseline interview (N =7,480). We also abstracted pQTL variants from other 
two genome-wide pQTL studies 
9, 23




 < 0.1) to construct new instruments for 
the risk-associated proteins. Both studies were conducted in the populations of European descent 
and the same SOMAscan platform was used to measure blood proteins. Genome-wide 
association analysis was performed to identify significant pQTL variants for circulating proteins 
11 
 
in the two studies. The aforementioned inverse-variance weighted method was applied to 
validate our primary findings. The potential pleiotropic effects of our genetic instruments were 
investigated via Phenoscanner 
24
. The lead pQTL variants for the identified proteins were 
queried.      
 
Results 
 We constructed genetic instruments for 1,469 out of the 1,478 proteins, using one to six 
genetic variants that were associated with the circulating concentration of each protein. Of the 
375 proteins whose concentrations could be predicted using multiple variants, 27 showed 
associations with overall breast cancer risk, after accounting for multiple comparisons (FDR < 
0.05, Table 1). Of them, the concentrations of 10 proteins were positively associated with breast 





), while the other 17 were inversely associated with the risk (ORs ranging from 0.90 




). The most noticeable association was 
observed for the immunoglobulin superfamily, particularly the leucine-rich repeat protein 2 
(ISLR2), of which the genetically predicted concentration was inversely associated with breast 
cancer risk (OR: 0.93, P = 5.20× 10
-8
). Analyses using single-variant instruments identified an 
additional 29 proteins at 11 loci, with their predicted circulating concentrations associated with 
overall breast cancer risk after accounting for multiple comparisons (FDR < 0.05, Table 2). The 
effect sizes of these associations were comparable and consistent in direction across the three 
independent datasets included in the BCAC for all associated proteins (supplementary Table S1).  
12 
 
 A recently reported breast cancer susceptibility locus, 9q34.2 (ABO) 
16
, showed strong 
pleiotropy with 32 risk-associated proteins. All of the instruments for these 32 protein 
biomarkers were constructed using genetic variants located at 9q34.2, alone or in combination 
with variants in other chromosomes. For instance, both genetically predicted concentrations of 
IGF1 receptors and insulin receptors were associated with a reduced risk of breast cancer 
(IGF1R: OR = 0.82, IR: OR =0.93, P = 3.28×10
-8
 for both proteins). Of the 32 proteins, 20 are 
membrane receptors and 11 are linked to the estrogen receptor via the ingenuity pathway 
analysis (supplementary Figure S1). The majority of the risk-associated proteins showed 
consistent associations for ER positive (+) and ER negative (-) breast cancer (supplementary 
Table S2). The association for seven of the proteins was stronger in risk of ER- than of ER+ 
breast cancer (Phet < 0.05 from heterogeneity tests, Table 3). 
 In the sensitivity analysis, we constructed new instruments using independent pQTL 
variants, with P < 5×10
-8
 for the 56 identified proteins (see Methods). The associations were not 
materially changed (Supplementary Table S3). Furthermore, we provided another source of 
validation via new instruments (see Methods). The associations of 27 proteins were replicated at 
P < 0.05 (Table 4). The pleiotropic effects of lead pQTL variants for the 56 proteins are 
presented in supplementary Table S4 (P < 5×10
-8
).  
We evaluated 55 of the 56 predicted protein biomarkers with breast cancer risk in the UK 
Biobank data (data for Fas ligand via rs371314787 were not available and no proxy could be 
identified within 500 Kb). Consistent associations were observed for 22 proteins with either 
histologically-confirmed or self-reported breast cancer risk (Table 5, P < 0.05). We also 





 The use of genetic variants as instrumental variables to assess the exposure-outcome 
relationship could help reduce confounding and selection bias, and eliminate biases due to 
reverse causation 
12
. Using data from a large-scale consortium (the BCAC), we identified 56 
circulating protein biomarkers associated with overall breast cancer risk, after adjusting for 
multiple comparisons. Of these, 22 associations were nominally replicated using data from the 
UK Biobank, providing assurance of the validity of our findings. Although the causality cannot 
be determined for the identified proteins, our study provides substantial new information about 
protein biomarker candidates for breast cancer risk.   
 A recently reported breast cancer susceptibility locus, 9q34.2 
16
, was related to more than 
half of the identified protein risk biomarkers. This region is known for its wide spectrum of 




, and proteins 
9, 10
, as well as its risk of 
coronary artery disease 
27
 and pancreatic cancer 
28
. The biological mechanisms underlying this 
pleiotropy remain obscure. The ingenuity pathway analysis revealed a network of multiple 
membrane proteins regulated by genetic variants in 9q34.2, such as insulin-like growth factor 1 
receptor (IGF1R), insulin receptor (IR), hepatocyte growth factor receptor (MET), neurogenic 
locus notch homolog protein 1 (NOTCH1), and vascular endothelial growth factor receptor 2 
(VEGFR2). All of these are linked to estrogen receptor signaling (Supplementary Figure S1) and 
insulin resistance 
29-32
. It is possible that the genetic variants in 9q34.2 may affect the 
concentration of these receptors, subsequently leading to impaired insulin sensitivity and/or 
abnormal estrogen signaling. Of note, the biological activities triggered by the contacts between 
ligands and these receptors are not limited to insulin resistance. Some examples are: 1) 
14 
 
insulin/IGF1 has a mitogenic effect on cell proliferation and growth through its binding to 
IR/IGF1R 
33
; 2) hepatocyte growth factor (HGF) and MET are important players in mammary 
gland development 
34
; 3) the notch signaling pathway is widely involved in diverse 
developmental and homeostatic processes 
35
; 4) VEGF/VEGFR2 interaction is responsible for 
developmental and pathological angiogenesis 
36
. Thus, the down-regulation of these receptors 
may trigger carcinogenic effects through elongated interactions with their ligands. However, the 
causality between specific proteins and breast cancer risk cannot be established due to the strong 
pleiotropy observed in this and several other loci. Nevertheless, these proteins can serve as 
candidate biomarkers for future studies. 
 We also identified associations for several other proteins that play important roles in 
various biological processes. For instance, we found that higher genetically predicted 
concentrations of copine 1and Fas ligand were associated with a reduced risk of overall breast 
cancer. Copine 1 belongs to calcium-dependent membrane-binding proteins. It has been shown 
that the interaction between copine 1 and p65 could repress the transcription of NF-κB, which is 
essential for cancer initiation and progression 
37
. Fas and Fas ligand’s role in apoptosis and 
immune homeostasis have long been acknowledged. By engaging Fas ligand with Fas in the 
cancer cell membrane, CD8+ cytotoxic lymphocytes can activate caspase 8 and initiate the 
apoptotic death of cancer cells 
38
. Thus, our analyses support the hypothesis that down-regulated 
copine 1 and Fas ligands may contribute to breast cancer risk. Another example is beta-1,3-N-
Acetylglucosaminyltransferase 2 (B3GNT2), which is the main polylactosamine synthase 
39
. Its 
important role in glycan formation (glycosylation) and its well-known link to aberrant 
glycosylation and carcinogenesis 
40
 support the hypothesis that the B3GNT2 protein may have a 
carcinogenic effect. The positive association we observed for genetically predicted B3GNT2 
15 
 
concentrations and breast cancer risk is consistent with a previous report that B3GNT2 




 The interpretation of some of our findings is less straightforward. For example, we 
identified an inverse correlation for a genetically predicted R-spondin 3 (RSPO3) concentration 
with breast cancer risk. R-spondins are critical regulators in the canonical Wnt/β-catenin 
pathway, and they have been shown to be activators of this pathway 
41
. It would be expected that 
excessive R-spondins may be positively related to breast cancer development, as the over-
activation of Wnt signaling is generally considered to be mechanistically related to cancer 
initiation 
42
. Similarly, we observed an inverse relationship between genetically predicted 
vascular cell adhesion protein 1 (VCAM1) concentrations and breast cancer risk, which deserves 
further investigation. VCAM1 has been widely studied for its role in promoting tumor 
angiogenesis, progression, and metastasis 
43
, but less for its effect on tumorigenesis. Thus, some 
of the associations observed in the present study should be interpreted cautiously, despite their 
statistical significance.     
 We evaluated multiple circulating protein biomarkers reported by previous 
epidemiological studies using genetic instruments. The results were not entirely consistent with 
previous findings. For example, we observed only a nominal association between genetically 
predicted CRP concentrations and overall breast cancer risk (OR: 1.04, P = 0.048), and the 
association was trivial after adjusting for multiple comparisons. This contradicts a recent meta-
analysis suggesting that an elevated circulating concentration of CRP may be associated with an 
increased breast cancer risk 
5, 44
. Of note, this association varied greatly between retrospective 
case-control studies and prospective cohort/nested case-control studies. Similarly, no association 
16 
 
was observed for the genetically predicted concentrations of IGF1 and HGF, which is in contrast 
with the findings for measured proteins in previous studies 
7, 38, 45
. These inconsistencies could be 
due to the inaccurate or confounded estimates of associations commonly encountered in 
traditional observational epidemiological studies. It is also possible that genetic instruments we 
used in this study are not adequate for the analysis.  
 Our study is unprecedented in its power to discover novel circulating protein biomarkers 
for breast cancer risk. Our findings also provide novel evidence revealing mechanistic networks 
underlying breast carcinogenesis. The identified proteins could serve as candidates in future 
investigations. Another great strength of this study is that we were able to validate a large 
number of our identified associations using an independent dataset from the UK Biobank. That 
we were able to replicate associations with breast cancer for 22 out of 55 proteins from an 
independent dataset cannot be explained by chance alone (binomial P = 5×10
-10
 when assuming 
5% of the associations could be replicated). We recognize that the number of breast cancer cases 
was relatively small in the UK Biobank and the SNP-breast cancer associations were derived 
from a linear regression model instead of a logistic regression model. The association estimates 
and 95% CIs might be biased; Thus, the design of replication stage was not ideal. We also 
recognize that the strong genetic pleiotropy, particularly at 9q34.2, prevents us from making 
causal inferences. Some of the associations may be largely attributable to the correlation between 
protein concentrations. In addition, our analysis depends on the number of proteins measured and 
the number of pQTLs identified in the GWAS of circulating protein concentrations. A more 
comprehensive analysis could be conducted when data becomes available for proteins that have 
not been evaluated in the current study. The explained variation in protein concentrations is also 
expected to improve with the identification of additional pQTLs. Lastly, all of the pQTLs 
17 
 
involved in the current analysis were identified in the blood. Whether these pQTLs were 
consistent in breast tissues remains unknown. However, we found that the coding genes of nearly 
all the proteins analyzed in the current study are expressed in the breast tissues from the 
Genotype-Tissue Expression project (data not shown).  
 The Strong pleiotropy of pQTL variants has limited our ability to infer causal roles of the 
identified proteins in breast cancer development. However, some pleiotropy may reveal potential 
intermediate phenotypes involved in the causal pathways for breast cancer. For example, 
rs2489623 (RSPO3) and rs7041 (JAG1) were associated with both central obesity and circulating 
25-OH vitamin D concentrations 
46-48
, respectively. Another example is that pQTLs at 3p21.31 
associated with multiple proteins (ADH1B, CRYBB2, DOCK9, STOM, TMPRSS11D, and 
TNS2) were also linked to age at menarche, which is an established risk factor for breast cancer. 
Additionally, solid evidence has linked the 9q34.2 (ABO) locus to invasive ovarian cancer risk 
49
. Thus, proteins associated with variants in 9q34.2 could be potential biomarkers for both 
malignancies.  
Although sensitivity analysis and extra replication were conducted, our findings should 
be interpreted with caution. To establish causality and understand the underlying mechanisms for 
the identified proteins in breast cancer etiology, assays at cell levels such as cell viability and 
colony formation assays, and whole-transcriptome profiling are potential next steps to depict the 
impact on breast cancer cell growth and gene-gene interplay networks, after knocking down the 
encoding genes.  
In summary, using genetic instruments, we identified 56 proteins with their genetically 
predicted circulating levels associated with breast cancer risk in this study. Future investigations 
18 
 
are needed to replicate our findings, particularly for the proteins that failed to reach statistical 
significance in the UK Biobank dataset. Understanding and establishing causality for the 
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Figure S1. Multiple identified proteins are relevant to estrogen receptor signaling 
The interplay of identified proteins were generated using the Ingenuity Pathway Analysis 
software. Several proteins associated with genetic variants in 9q34.2 (ABO) are linked to 

















Table 1. Associations between genetically predicted concentrations of circulating proteins 
and breast cancer risk using multi-variant instruments 







C1GALT1C1 rs2519093, rs7787942 1.06 (1.04-1.09) 1.19×10
-7
 
ALPI rs550057, rs679574 0.90 (0.87-0.94) 8.61×10
-7
 









CPNE1 rs12481228, rs62143206 0.96 (0.95-0.98) 4.69×10
-5
 
RELT rs3741148, rs7952686 1.07 (1.03-1.10) 6.06×10
-5
 





















QSOX2 rs10858248, rs149092047 1.03 (1.01-1.04) 1.67×10
-4
 









KLRF1 rs11708955, rs62143194 1.10 (1.05-1.16) 2.72×10
-4
 









CAMK1 rs4525, rs61751507 0.98 (0.96-0.99) 3.53×10
-4
 
GOLM1 rs149092047, rs601338 1.04 (1.02-1.06) 4.11×10
-4
 
BCAM rs144579705, rs8176747 0.92 (0.88-0.96) 5.48×10
-4
 
AKR1A1 rs62143198, rs72688441 0.97 (0.96-0.99) 9.68×10
-4
 
THSD1 rs2519093, rs41292808 0.95 (0.92-0.98) 1.14×10
-3
 
































Table 2. Associations between genetically predicted concentrations of circulating proteins and breast cancer risk 




Locus Protein ORs P values 
rs2519093
a
 9q34.2, ABO 
IGF1R (soluble), IR, MET, 
IL3RA, SELE (soluble), ENG, 
LIFR (soluble), FAM20B, 
ICAM2 (soluble),  CHST15 







rs3184504 12q24.12, SH2B3 VCAM1 0.85 4.09×10
-7
 
rs3197999 3p21.31, MST1 
TMPRSS11D, DOCK9, TNS2, 
CRYBB2 
1.06 to 1.16 2.51×10
-5
 





 3p21.31, BSN STOM, ADH1B 1.06 7.17×10
-5
 
rs371314787 3p21.31, APEH FASLG (soluble) 0.89 1.58×10
-4
 





















rs2489623 6q22.33, RSPO3  RSPO3 0.92 6.82×10
-4
 

























Table 3. Associations between genetically predicted concentrations of circulating proteins 
and breast cancer risk differed by ER status: analysis using genetic instruments  
 Estrogen receptor +  Estrogen receptor  -  
Protein OR (95% CI) P  OR (95% CI) P Phet 
TMPRSS11D 1.06 (1.03-1.09) 1.41×10
-4
  1.13 (1.08-1.19) 4.00×10
-7
 0.026 
DOCK9 1.11 (1.05-1.17) 1.41×10
-4
  1.25 (1.14-1.36) 4.00×10
-7
 0.024 
TNS2 1.09 (1.04-1.13) 1.41×10
-4
  1.19 (1.11-1.27) 4.00×10
-7
 0.03 
CRYBB2 1.17 (1.08-1.27) 1.41×10
-4
  1.39 (1.22-1.58) 4.00×10
-7
 0.027 
STOM 1.06 (1.03-1.10) 6.11×10
-4
  1.14 (1.08-1.20) 1.50×10
-6
 0.022 
ADH1B 1.07 (1.03-1.11) 6.10×10
-4
  1.16 (1.09-1.23) 1.60×10
-6
 0.026 









Table 4. Validation of primary results with instruments constructed using pQTL variants from 
independent studies 
Protein Protein-associated SNPs  OR (95% CI) P value Consistent in direction 
SELP rs10800462, rs651007 0.94 (0.92-0.97) 1.89×10
-4
 Yes 
CPNE1 rs2425143 0.97 (0.95-0.98) 4.10×10
-5
 Yes 
RELT rs7119167 1.06 (1.02-1.10) 3.91×10
-3
 Yes 
VEGFR3/FLT4 rs10935480, rs651007 0.97 (0.96-0.99) 5.50×10
-4
 Yes 
VEGFR2/KDR rs34231037, rs651007 0.96 (0.94-0.99) 7.49×10
-3
 Yes 
TIE1 (soluble) rs10935480, rs8176749 0.97 (0.95-0.99) 6.57×10
-4
 Yes 
BCAM rs8176749 0.93 (0.89-0.97) 7.49×10
-4
 Yes 
AKR1A1 rs6662572 0.97 (0.93-1.01) 1.72×10
-1
 Yes 
JAG1 rs4588, rs651007 0.95 (0.92-0.98) 1.07×10
-3
 Yes 
IR rs651007 0.95 (0.93-0.97) 8.30×10
-7
 Yes 
MET rs35349146, rs651007 0.93 (0.90-0.96) 7.20×10
-6
 Yes 
SELE (soluble) rs651007 0.96 (0.95-0.98) 8.30×10
-7
 Yes 
ENG rs651007 0.93 (0.91-0.96) 8.30×10
-7
 Yes 
ICAM2 (soluble) rs651007 0.91 (0.88-0.95) 8.30×10
-7
 Yes 
CHST15 rs651007 0.90 (0.87-0.94) 8.30×10
-7
 Yes 
TFPI rs6027 0.97 (0.92-1.01) 1.76×10
-1
 No 
CD36 rs651007 0.93 (0.91-0.96) 8.30×10
-7
 Yes 
NOTCH1 rs8176749 0.92 (0.87-0.96) 7.49×10
-4
 Yes 
CDH5 rs8176749 0.97 (0.95-0.99) 7.49×10
-4
 Yes 
ALPI rs4942471 1.07 (0.99-1.15) 9.51×10
-2
 No 
B3GNT2 rs1800470, rs492488 1.04 (0.99-1.08) 1.05×10
-1
 Yes 
C1GALT1C1 rs579459 1.12 (1.07-1.17) 7.40×10
-7
 Yes 
CTSF rs607736 1.18 (1.10-1.27) 1.30×10
-5
 Yes 
FAM177A1 rs492488, rs799498 0.99 (0.96-1.01) 3.18×10
-1
 - 
GOLM1 rs492488, rs7854118 1.03 (1.00-1.06) 4.58×10
-2
 Yes 
ISLR2 rs579459, rs923118 0.94 (0.91-0.97) 1.42×10
-4
 Yes 





MAN1A2 rs1289863 0.95 (0.89-1.02) 1.41×10
-1
 No 
PRDM1 rs9852529 1.08 (1.04-1.13) 7.60×10
-5
 Yes 
QSOX2 rs12378344, rs492488 1.03 (1.01-1.05) 2.22×10
-3
 Yes 
RSPO3 rs3734626 0.94 (0.91-0.98) 1.51×10
-3
 Yes 
SCG3 rs1456297 1.05 (1.02-1.09) 1.08×10
-3
 Yes 
SEC13 rs62295996 0.99 (0.92-1.07) 8.45×10
-1
 - 
SULF2 rs7485577 0.97 (0.91-1.03) 3.43×10
-1
 - 
THSD1 rs704 0.97 (0.92-1.02) 1.90×10
-1
 Yes 
TMPRSS11D rs9852529 1.09 (1.04-1.13) 7.60×10
-5
 Yes 






Table 5. Protein biomarkers replicated using data from the UK Biobank: associations of genetically predicted 
concentrations of circulating proteins with breast cancer risk  
  
Histologically 


















+ 0.003  + 0.007 
HTN1 rs1063945 
a






- 0.007  - 0.044 
VCAM1 rs3184504 - 0.010  - 0.063 
RSPO3 rs2489623 - 0.014  - 0.240 
CHST15 rs550057 
a






- 0.016  - 0.011 
JAG1 rs7041, rs550057 
a
 - 0.017  - 0.068 
ALPI rs679574, rs550057 
a
 - 0.025  - 0.068 
FAM177A1 rs679574, rs550057 
a
 - 0.029  - 0.086 
IGFIR (soluble), MET, ICAM2 






 0.040  -/+ 
b
 0.012 
IR rs507666 - 0.042  - 0.012 
MAN1A2  rs532436 
a
 + 0.044  + 0.015 




+ 0.048  + 0.029 
GOLM1 rs601338, rs550057 
a








- 0.084  - 0.053 







- 0.207  - 0.088 
a 
Proxy SNPs were used (R
2 
> 0.9 in the 1000 Genome Project CEU population) 
b 
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eTable 1. Associations between genetically predicted concentrations of circulating proteins and overall breast cancer risk: by BCAC sub-study 
      GWAS   iCOGS   OncoArray 
Protein Protein-associated SNPs   OR (95% CI) p   OR (95% CI) p   OR (95% CI) p 
SELE (soluble) rs2519093   0.97 (0.94-1.01) 0.13   0.95 (0.93-0.97) 2.02×10
-6
   0.97 (0.95-0.99) 0.003 
IL3RA rs2519093   0.96 (0.91-1.01) 0.13   0.93 (0.91-0.96) 2.02×10
-6
   0.96 (0.94-0.99) 0.003 
MET rs635634   0.91 (0.81-1.02) 0.12   0.85 (0.80-0.91) 1.83×10
-6
   0.92 (0.87-0.97) 0.004 
ENG rs635634   0.86 (0.72-1.04) 0.12   0.78 (0.70-0.86) 1.83×10
-6
   0.87 (0.80-0.96) 0.004 
IGF1R (soluble) rs635634   0.85 (0.70-1.04) 0.12   0.76 (0.68-0.85) 1.83×10
-6
   0.86 (0.78-0.96) 0.004 
IR rs507666   0.94 (0.88-1.02) 0.12   0.90 (0.87-0.94) 2.24×10
-6
   0.94 (0.91-0.98) 0.003 
LIFR (soluble) rs635634   0.89 (0.77-1.03) 0.12   0.82 (0.75-0.89) 1.83×10
-6
   0.90 (0.84-0.97) 0.004 
FAM20B rs587729126   1.16 (0.97-1.38) 0.1   1.24 (1.13-1.36) 6.50×10
-6
   1.13 (1.04-1.23) 0.003 
ICAM2 (soluble) rs587729126   0.85 (0.70-1.03) 0.1   0.79 (0.71-0.87) 6.50×10
-6
   0.87 (0.80-0.95) 0.003 
ISLR2 rs115478735,rs2959011,rs4055121   0.94 (0.87-1.02) 0.12   0.91 (0.87-0.95) 3.34×10
-5
   0.94 (0.90-0.97) 0.001 
C1GALT1C1 rs2519093,rs7787942   1.06 (0.99-1.12) 0.09   1.08 (1.04-1.12) 3.79×10
-5
   1.05 (1.02-1.08) 0.002 
VCAM1 rs3184504   0.78 (0.65-0.94) 0.01   0.84 (0.76-0.93) 0.001   0.87 (0.79-0.95) 0.003 
ALPI rs550057,rs679574   1.01 (0.90-1.13) 0.92   0.86 (0.81-0.92) 8.10×10
-6
   0.91 (0.86-0.97) 0.002 
FAM177A1 rs550057,rs679574   1.01 (0.90-1.13) 0.93   0.87 (0.82-0.92) 1.08×10
-5
   0.92 (0.86-0.97) 0.003 
CHST15 rs550057   1.02 (0.90-1.15) 0.78   0.87 (0.81-0.93) 2.01×10
-5
   0.91 (0.85-0.96) 0.002 
SELP rs2519093,rs6136,rs74227709   0.95 (0.90-1.00) 0.07   0.95 (0.92-0.98) 3.30×10
-4
   0.97 (0.94-1.00) 0.053 
TMPRSS11D rs3197999   1.04 (0.96-1.12) 0.35   1.06 (1.02-1.10) 0.005   1.06 (1.02-1.10) 0.002 
DOCK9 rs3197999   1.07 (0.93-1.23) 0.35   1.11 (1.03-1.19) 0.005   1.11 (1.04-1.19) 0.002 
TNS2 rs3197999   1.05 (0.95-1.17) 0.35   1.08 (1.02-1.14) 0.005   1.08 (1.03-1.14) 0.002 
CRYBB2 rs3197999   1.10 (0.90-1.36) 0.35   1.17 (1.05-1.30) 0.005   1.17 (1.06-1.29) 0.002 
HTN1 rs151288400   1.09 (0.96-1.24) 0.19   1.13 (1.06-1.21) 4.32×10
-4
   1.06 (1.00-1.13) 0.044 
CPNE1 rs12481228,rs62143206   0.93 (0.88-0.98) 0   0.98 (0.95-1.00) 0.092   0.96 (0.94-0.99) 0.004 
RELT rs3741148,rs7952686   0.99 (0.91-1.08) 0.83   1.09 (1.04-1.14) 8.12×10
-4
   1.07 (1.02-1.12) 0.004 
STOM rs6770670   1.04 (0.96-1.14) 0.32   1.06 (1.02-1.11) 0.008   1.06 (1.02-1.10) 0.005 
ADH1B rs13085791   1.05 (0.95-1.16) 0.33   1.07 (1.02-1.12) 0.008   1.07 (1.02-1.12) 0.005 
CTSF rs11347749,rs1791679   1.07 (0.97-1.19) 0.2   1.10 (1.03-1.16) 0.002   1.06 (1.01-1.12) 0.023 
TPST2 rs115478735,rs2283824,rs34436714   1.06 (0.97-1.16) 0.22   1.06 (1.01-1.12) 0.026   1.07 (1.02-1.12) 0.004 
VEGFR3/FLT4 rs10935473,rs2519093,rs34221241   0.99 (0.95-1.03) 0.65   0.97 (0.94-0.99) 0.007   0.97 (0.95-0.99) 0.005 
FASLG (soluble) rs371314787   0.98 (0.80-1.20) 0.85   0.87 (0.79-0.96) 0.006   0.88 (0.81-0.96) 0.005 
KIN rs149092047,rs62143198,rs7412   0.96 (0.88-1.06) 0.47   0.93 (0.88-0.97) 0.002   0.95 (0.91-0.99) 0.026 
QSO×2 rs10858248,rs149092047   1.00 (0.95-1.04) 0.82   1.04 (1.01-1.06) 0.002   1.03 (1.01-1.05) 0.008 
B3GNT2 rs2519093,rs67047091   1.01 (0.94-1.09) 0.74   1.06 (1.02-1.11) 0.003   1.04 (1.01-1.08) 0.013 
VEGFR2/KDR rs34231037,rs34336071,rs635634   0.99 (0.93-1.05) 0.69   0.95 (0.92-0.98) 0.003   0.97 (0.94-0.99) 0.018 
KLRF1 rs11708955,rs62143194   1.13 (0.95-1.33) 0.16   1.10 (1.01-1.20) 0.026   1.10 (1.02-1.18) 0.013 
MAN1A2 rs35505705,rs8176643   1.07 (0.92-1.24) 0.39   1.10 (1.03-1.18) 0.006   1.07 (1.01-1.14) 0.023 
TIE1 (soluble) rs10935473,rs2275180,rs8176743   0.94 (0.89-0.99) 0.01   0.96 (0.94-0.99) 0.012   0.98 (0.95-1.00) 0.099 
CAMK1 rs4525,rs61751507   0.97 (0.94-1.01) 0.11   0.98 (0.96-1.00) 0.048   0.98 (0.96-0.99) 0.01 
GAL rs2205895   0.85 (0.70-1.03) 0.1   0.87 (0.78-0.97) 0.01   0.90 (0.82-1.00) 0.049 
GOLM1 rs149092047,rs601338   1.00 (0.94-1.07) 0.94   1.05 (1.02-1.09) 0.004   1.04 (1.01-1.07) 0.017 
SEC13 rs1800594   0.80 (0.65-0.97) 0.02   0.91 (0.82-1.02) 0.106   0.88 (0.80-0.98) 0.016 
BCAM rs144579705,rs8176747   0.79 (0.68-0.92) 0   0.91 (0.84-0.99) 0.033   0.95 (0.89-1.01) 0.075 
CD36 rs8176693   0.84 (0.75-0.94) 0   0.91 (0.86-0.97) 0.004   0.98 (0.93-1.03) 0.445 
NOTCH1 rs8176743   0.75 (0.63-0.90) 0   0.87 (0.78-0.96) 0.005   0.96 (0.88-1.05) 0.409 
RSPO3 rs2489623   0.99 (0.88-1.13) 0.93   0.90 (0.84-0.97) 0.005   0.92 (0.87-0.99) 0.019 
TLL1 rs8176747   0.82 (0.73-0.93) 0   0.91 (0.85-0.97) 0.005   0.97 (0.92-1.04) 0.428 
CDH5 rs8176746   0.92 (0.87-0.97) 0   0.96 (0.93-0.99) 0.005   0.99 (0.96-1.02) 0.426 
AKR1A1 rs62143198,rs72688441   0.95 (0.91-1.00) 0.06   0.98 (0.95-1.00) 0.082   0.97 (0.95-1.00) 0.026 
THSD1 rs2519093,rs41292808   0.93 (0.84-1.03) 0.16   0.93 (0.88-0.98) 0.007   0.96 (0.92-1.01) 0.116 
PSD rs1303,rs429358   1.01 (0.95-1.07) 0.79   0.97 (0.93-1.01) 0.104   0.95 (0.92-0.98) 7.83×10
-4
 
SULF2 rs10424405,rs7614709,rs7971133   0.92 (0.83-1.02) 0.1   0.95 (0.90-1.01) 0.1   0.94 (0.90-0.99) 0.02 
SCG3 rs1378892   1.08 (0.99-1.18) 0.1   1.06 (1.02-1.11) 0.009   1.03 (0.99-1.08) 0.143 
PRDM1 rs13093385,rs2232613   1.03 (0.97-1.09) 0.3   1.04 (1.01-1.07) 0.016   1.03 (1.00-1.05) 0.065 
TFPI rs10800453   1.13 (0.99-1.30) 0.08   1.06 (0.98-1.15) 0.126   1.09 (1.01-1.17) 0.02 
SEMA6A rs3733724,rs56278466,rs8176743   0.87 (0.78-0.97) 0.01   0.92 (0.87-0.98) 0.008   0.98 (0.93-1.03) 0.388 
JAG1 rs550057,rs7041   1.07 (0.95-1.21) 0.24   0.92 (0.86-0.99) 0.016   0.91 (0.86-0.97) 0.003 
PTGR1 rs148410779   0.95 (0.83-1.08) 0.44   0.94 (0.87-1.00) 2.02×10
-6









eTable 2. Associations between genetically predicted concentrations of circulating proteins and breast 
cancer risk by ER status: analysis using genetic instruments   
  Estrogen receptor +   Estrogen receptor  -   
Protein OR (95% CI) 
 
  OR (95% CI) P Phet 
SELE (soluble) 0.96 (0.95-0.98) 5.20×10
-6
   0.97 (0.95-0.99) 0.013 0.432 
IL3RA 0.95 (0.93-0.97) 5.20×10
-6
   0.96 (0.93-0.99) 0.013 0.586 
MET 0.90 (0.85-0.94) 6.00×10
-6
   0.91 (0.85-0.98) 0.017 0.804 
ENG 0.84 (0.78-0.90) 6.00×10
-6
   0.87 (0.77-0.97) 0.017 0.613 
IGFIR (soluble) 0.82 (0.76-0.90) 6.00×10
-6
   0.86 (0.75-0.97) 0.017 0.544 
IR 0.93 (0.90-0.96) 5.20×10
-6
   0.94 (0.90-0.99) 0.014 0.716 
LIFR (soluble) 0.87 (0.82-0.92) 6.00×10
-6
   0.89 (0.81-0.98) 0.017 0.689 
FAM20B 1.16 (1.08-1.24) 2.30×10
-5
   1.16 (1.04-1.29) 0.008 1 
ICAM2 (soluble) 0.85 (0.79-0.92) 2.30×10
-5
   0.85 (0.76-0.96) 0.008 1 
ISLR2 0.93 (0.90-0.96) 1.30×10
-5
   0.94 (0.89-0.98) 0.009 0.718 
C1GALT1C1 1.06 (1.03-1.09) 1.30×10
-5
   1.07 (1.02-1.11) 0.002 0.718 
VCAM1 0.85 (0.79-0.92) 4.80×10
-5
   0.84 (0.74-0.94) 0.003 0.87 
ALPI 0.90 (0.86-0.94) 2.10×10
-5
   0.96 (0.89-1.04) 0.317 0.158 
FAM177A1 0.90 (0.86-0.95) 2.80×10
-5
   0.97 (0.90-1.04) 0.349 0.094 
CHST15 0.90 (0.86-0.94) 2.60×10
-5
   0.94 (0.87-1.01) 0.091 0.326 
SELP 0.96 (0.94-0.98) 7.86×10
-4
   0.96 (0.92-0.99) 0.017 1 
TMPRSS11D 1.06 (1.03-1.09) 1.41×10
-4
   1.13 (1.08-1.19) 4.00×10
-7
 0.026 
DOCK9 1.11 (1.05-1.17) 1.41×10
-4
   1.25 (1.14-1.36) 4.00×10
-7
 0.024 
TNS2 1.09 (1.04-1.13) 1.41×10
-4
   1.19 (1.11-1.27) 4.00×10
-7
 0.03 
CRYBB2 1.17 (1.08-1.27) 1.41×10
-4
   1.39 (1.22-1.58) 4.00×10
-7
 0.027 
HTN1 1.09 (1.04-1.15) 6.59×10
-4
   1.13 (1.04-1.22) 0.002 0.454 
CPNE1 0.96 (0.94-0.98) 6.17×10
-4
   0.97 (0.94-1.00) 0.054 0.586 
RELT 1.07 (1.03-1.11) 5.54×10
-4
   1.01 (0.95-1.07) 0.82 0.107 
STOM 1.06 (1.03-1.10) 6.11×10
-4
   1.14 (1.08-1.20) 1.50×10
-6
 0.022 
ADH1B 1.07 (1.03-1.11) 6.10×10
-4
   1.16 (1.09-1.23) 1.60×10
-6
 0.026 
CTSF 1.08 (1.04-1.13) 2.41×10
-4
   1.08 (1.01-1.16) 0.017 1 
TPST2 1.06 (1.02-1.10) 0.001   1.07 (1.01-1.13) 0.021 0.786 
VEGFR3/FLT4 0.97 (0.95-0.98) 8.60×10
-5
   0.98 (0.96-1.01) 0.226 0.499 
FASLG (soluble) 0.88 (0.82-0.95) 0.001   0.75 (0.67-0.84) 1.60×10
-6
 0.02 
KIN 0.94 (0.91-0.98) 9.97×10
-4
   0.97 (0.92-1.03) 0.365 0.362 
QSOX2 1.03 (1.01-1.04) 0.002   1.02 (0.99-1.05) 0.117 0.561 
B3GNT2 1.05 (1.02-1.09) 5.80×10
-4
   1.03 (0.98-1.08) 0.234 0.522 
VEGFR2/KDR 0.96 (0.93-0.98) 2.76×10
-4
   0.99 (0.95-1.02) 0.462 0.172 
KLRF1 1.10 (1.03-1.17) 0.003   1.20 (1.08-1.32) 3.47×10
-4
 0.151 
MAN1A2 1.07 (1.02-1.13) 0.006   1.04 (0.96-1.13) 0.293 0.563 
TIE1 (soluble) 0.96 (0.94-0.98) 6.59×10
-4
   0.97 (0.94-1.00) 0.083 0.586 
CAMK1 0.98 (0.97-1.00) 0.021   0.98 (0.96-1.00) 0.081 1 
GAL 0.90 (0.82-0.97) 0.008   0.97 (0.85-1.10) 0.626 0.34 
GOLM1 1.04 (1.01-1.07) 0.002   1.04 (1.00-1.09) 0.041 1 
SEC13 0.90 (0.83-0.98) 0.016   0.89 (0.78-1.01) 0.063 0.887 
BCAM 0.91 (0.86-0.96) 0.001   0.91 (0.84-0.99) 0.035 1 
CD36 0.93 (0.89-0.98) 0.004   0.93 (0.86-0.99) 0.031 1 
NOTCH1 0.90 (0.83-0.97) 0.005   0.88 (0.79-0.99) 0.037 0.748 
RSPO3 0.92 (0.87-0.97) 0.002   0.90 (0.83-0.98) 0.012 0.664 
TLL1 0.93 (0.88-0.98) 0.005   0.92 (0.85-1.00) 0.039 0.828 
CDH5 0.97 (0.95-0.99) 0.005   0.96 (0.93-1.00) 0.039 0.627 
AKR1A1 0.97 (0.95-0.99) 0.005   0.99 (0.96-1.02) 0.45 0.275 
THSD1 0.95 (0.91-0.98) 0.005   0.96 (0.90-1.02) 0.175 0.778 
PSD 0.95 (0.93-0.98) 5.70×10
-4
   0.98 (0.94-1.02) 0.373 0.209 
SULF2 0.95 (0.91-0.99) 0.015   0.96 (0.90-1.03) 0.243 0.796 
SCG3 1.06 (1.02-1.10) 9.44×10
-4
   1.02 (0.97-1.08) 0.407 0.251 
PRDM1 1.03 (1.01-1.05) 0.013   1.08 (1.05-1.12) 6.20×10
-6
 0.014 
TFPI 1.06 (1.00-1.13) 0.05   1.09 (0.99-1.19) 0.07 0.62 
SEMA6A 0.94 (0.90-0.98) 0.003   0.94 (0.88-1.00) 0.059 1 
JAG1 0.92 (0.87-0.96) 5.71×10
-4
   0.97 (0.90-1.05) 0.454 0.257 
PTGR1 0.91 (0.86-0.96) 8.30×10
-4
   0.95 (0.87-1.03) 0.23 0.403 
 
 
eTable 3. Associations between genetically predicted concentrations of circulating proteins and breast cancer risk using multi-variant 
instruments constructed by pQTL variants with P < 5×10
-8
 
Protein OR (95% CI) P  Protein-associated SNPs 
ICAM2 0.82 (0.78-0.87) 1.33×10
-13
 12:111884608:T:C, 9:136138765:GCGCCCACCACTA:G  
INSR 0.93 (0.91-0.95) 8.29×10
-10
 rs760459, rs60484807, 9:136149399:G:A  
SELE 0.96 (0.95-0.98) 4.70×10
-9
 rs12288924, rs11603123, rs35434910, rs635634, rs116851371  
C1GALT1C1 1.06 (1.04-1.08) 8.98×10
-9
 rs9267920, rs7787942, rs8176765, 9:136141870:C:T 
IL3RA 0.96 (0.94-0.97) 9.15×10
-9
 rs9264642, rs7772305, rs3128759, rs12378537, 9:136141870:C:T  
ENG 0.83 (0.78-0.89) 3.60×10
-8
 rs635634 
IGF1R 0.82 (0.76-0.88) 3.60×10
-8
 rs635634 
LIFR 0.87 (0.82-0.91) 3.60×10
-8
 rs635634 
TMPRSS11D 1.06 (1.04-1.08) 3.68×10
-8
 rs78691034, rs7640031, rs71324929, rs63714761, rs3197999, rs36101994 
SEMA6A 0.92 (0.89-0.95) 8.16×10
-8
 rs56278466, rs3733724, rs8176743, 9:136146597:C:T  
ALPI 0.90 (0.87-0.94) 8.61×10
-7
 rs679574, 9:136146597:C:T 
TNS2 1.08 (1.04-1.11) 9.72×10
-7
 rs12492271, rs6773261, rs3197999 
DOCK9 1.10 (1.06-1.15) 1.10×10
-6
 rs11710798, rs3197999 
MET 0.92 (0.89-0.96) 4.46×10
-6
 rs1858830, rs6955032, rs635634 
STOM 1.06 (1.03-1.08) 7.22×10
-6
 rs78691034, rs13084000, rs6770670 
FLT4 0.96 (0.94-0.98) 7.33×10
-6
 rs115410474, rs73133989, rs6762552, rs34221241, 9:136141870:C:T  
FAM20B 1.09 (1.05-1.14) 3.45×10
-5
 rs12064702, rs62143198, 9:136138765:GCGCCCACCACTA:G 
PRDM1 1.03 (1.02-1.05) 3.94×10
-5
 
rs2232613, rs144645644, rs2291903, rs78691034, rs78700949, rs11709092, 
rs143916056 rs11713251, rs374609508, rs63714761, rs13093385, rs138621393 
HTN1 1.09 (1.05-1.14) 5.10×10
-5
 rs151288400           
VCAM1 0.91 (0.87-0.95) 5.13×10
-5
 12:111884608:T:C, rs1257168, rs80286094         
CAMK1 0.97 (0.96-0.99) 5.41×10
-5
 rs57904876, rs78328556, rs1557570, rs61751507, rs72706368       
SEC13 0.91 (0.88-0.96) 5.58×10
-5
 rs1800594, rs3766126, rs927826         
ISLR2 0.95 (0.92-0.97) 8.89×10
-5
 rs4055121, rs2959011, rs10793962         
TPST2 1.06 (1.03-1.09) 1.17×10
-4
 rs35139041, rs34436714, rs2283824, rs115478735        
QSO×2 1.03 (1.01-1.04) 1.26×10
-4
 9:136146597:C:T, rs116851371, rs10858248         
FASLG 0.89 (0.83-0.94) 1.51×10
-4
 3:49709912:C:CT           
RSPO3 0.93 (0.89-0.96) 1.73×10
-4
 rs80010360, rs2489623          
SELP 0.97 (0.95-0.98) 1.78×10
-4
 
rs182855188, rs140217668, rs6136, rs2235303, rs41315846, rs74227709, rs9820851 
rs6993770, 9:136141870:C:T   
CHST15 0.93 (0.90-0.97) 1.84×10
-4
 rs7247412, 9:136146597:C:T          
RELT 1.06 (1.03-1.09) 2.01×10
-4
 rs3741148, rs7952686, rs71640036         
MAN1A2 1.06 (1.03-1.09) 2.65×10
-4
 rs7548848 rs7512060 rs41296190 rs114047680 rs10418046 rs8176643      
CPNE1 0.97 (0.96-0.99) 2.74×10
-4
 
rs62143206 rs139295665 rs145186586 rs2248393 rs12481228 20:34436780:TA:T 
20:34555466:TA:T, rs11908144 
ADH1B 1.05 (1.02-1.08) 2.81×10
-4
 rs78844723, rs11709092, rs13085791 
TIE1 0.97 (0.95-0.99) 3.32×10
-4
 rs2275180, rs10935473, rs8176743         
GOLM1 1.04 (1.02-1.06) 4.11×10
-4
 rs601338, 9:136139907:GAAACTGCC:G          
B3GNT2 1.04 (1.02-1.06) 4.14×10
-4
 rs284647, rs67047091, rs12986356, rs679574, rs11375378, rs4073090 9:136141870:C:T     
TFPI 1.07 (1.03-1.11) 4.16×10
-4
 rs9332701, rs10800453, rs6025, rs11596680        
BCAM 0.92 (0.88-0.96) 4.45×10
-4
 rs28399656, rs8176747          
PSD 0.96 (0.94-0.98) 4.77×10
-4
 rs1303, rs157580, rs429358, rs74480769        
KIN 0.95 (0.93-0.98) 4.97×10
-4
 rs73515693, rs7412, rs62143198, rs3917549, 9:136139907:GAAACTGCC:G       
CD36 0.93 (0.90-0.97) 6.01×10
-4
 rs8176693           
NOTCH1 0.90 (0.84-0.95) 6.56×10
-4
 rs8176743           
TLL1 0.93 (0.89-0.97) 7.13×10
-4
 rs8176747           
PTGR1 0.95 (0.92-0.98) 8.01×10
-4
 rs76461890, rs144875739, rs148410779         
KDR 0.97 (0.95-0.99) 8.06×10
-4
 rs34336071, rs34231037, rs2305948, rs116245354, rs1380069, rs184838577, rs635634     
THSD1 0.95 (0.92-0.98) 1.39×10
-3
 rs76603855, rs41292808, 9:136141870:C:T         
CDH5 0.97 (0.96-0.99) 1.53×10
-3
 rs2289150, rs7859473, rs8176746 rs2519145        
JAG1 0.93 (0.90-0.97) 1.56×10
-3
 rs7041, 9:136146597:C:T          
AKR1A1 0.98 (0.96-0.99) 2.62×10
-3
 
rs116512105, rs113825465, 1:45565962:C:T, rs60515365, rs72688441, rs10416363 
rs62143198, rs139295665    
KLRF1 1.07 (1.02-1.12) 2.70×10
-3
 rs62143194, rs77271561, rs11708955         
SULF2 0.95 (0.92-0.98) 2.87×10
-3
 12:57770098:C:T, rs117978438, rs10424405, rs7614709        
CTSF 1.05 (1.01-1.08) 4.53×10
-3
 rs1791679, 12:102212154:CT:C, rs1260326         
GAL 0.94 (0.90-0.99) 8.74×10
-3
 rs72708013, rs2205895, rs1409338         
SCG3 1.03 (1.00-1.05) 3.29×10
-2
 rs35696230, 15:51822784:TA:T, rs1378892, rs2305710        
FAM177A1 0.98 (0.96-1.00) 4.61×10
-2
 rs799473, rs140182729, rs8013122, rs679574, 9:136146597:C:T       
CRYBB2 1.05 (1.00-1.10) 4.98×10
-2
 rs4774039, rs3197999, rs4576502         








eTable 4. Compiled pleiotropic effects of pQTL variants used to construct instruments for the 56 identified proteins 
pQTL SNPs Protein Chr BP  A1 A2 Trait Ancestry PMID 
rs13085791 ADH1B 3 49721798 A C High light scatter percentage of red cells European 27863252 
rs13085791 ADH1B 3 49721798 A C High light scatter reticulocyte count European 27863252 
rs13085791 ADH1B 3 49721798 A C Immature fraction of reticulocytes European 27863252 
rs13085791 ADH1B 3 49721798 A C Mean corpuscular volume European 27863252 
rs13085791 ADH1B 3 49721798 A C Reticulocyte count European 27863252 
rs13085791 ADH1B 3 49721798 A C Reticulocyte fraction of red cells European 27863252 
rs13085791 ADH1B 3 49721798 A C Age first birth European 27798627 
rs13085791 ADH1B 3 49721798 A C Crohns disease European 26192919 
rs13085791 ADH1B 3 49721798 A C Inflammatory bowel disease European 26192919 
rs13085791 ADH1B 3 49721798 A C Ulcerative colitis European 26192919 
rs13085791 ADH1B 3 49721798 A C Primary sclerosing cholangitis European 27992413 
rs13085791 ADH1B 3 49721798 A C Age at menarche European 25231870 
rs13085791 ADH1B 3 49721798 A C Years of educational attainment in females European 27225129 
rs13085791 ADH1B 3 49721798 A C Years of educational attainment in males European 27225129 
rs13085791 ADH1B 3 49721798 A C Years of educational attainment European 27225129 
rs62143198 AKR1A1 19 54320939 A G Granulocyte percentage of myeloid white cells European 27863252 
rs62143198 AKR1A1 19 54320939 A G Monocyte count European 27863252 
rs62143198 AKR1A1 19 54320939 A G Monocyte percentage of white cells European 27863252 
rs550057 ALPI 9 136146597 C T Granulocyte count European 27863252 
rs550057 ALPI 9 136146597 C T Hematocrit European 27863252 
rs550057 ALPI 9 136146597 C T Hemoglobin concentration European 27863252 
rs550057 ALPI 9 136146597 C T Mean corpuscular volume European 27863252 
rs550057 ALPI 9 136146597 C T Monocyte count European 27863252 
rs550057 ALPI 9 136146597 C T Myeloid white cell count European 27863252 
rs550057 ALPI 9 136146597 C T Neutrophil count European 27863252 
rs550057 ALPI 9 136146597 C T Red blood cell count European 27863252 
rs550057 ALPI 9 136146597 C T Red cell distribution width European 27863252 
rs550057 ALPI 9 136146597 C T Sum basophil neutrophil counts European 27863252 
rs550057 ALPI 9 136146597 C T Sum neutrophil eosinophil counts European 27863252 
rs550057 ALPI 9 136146597 C T White blood cell count European 27863252 
rs550057 ALPI 9 136146597 C T Coronary artery disease Mixed 26343387 
rs550057 ALPI 9 136146597 C T Myocardial infarction Mixed 26343387 
rs550057 ALPI 9 136146597 C T Venous thrombosis European 22675575 
rs550057 ALPI 9 136146597 C T LDL cholesterol European 25961943 
rs550057 ALPI 9 136146597 C T High grade serous ovarian cancer European 28346442 
rs550057 ALPI 9 136146597 C T Serous invasive ovarian cancer European 28346442 
rs550057 ALPI 9 136146597 C T Alkaline phosphatase European 28887542 
rs550057 ALPI 9 136146597 C T Ferritin European 28887542 
rs550057 ALPI 9 136146597 C T Coronary artery disease Mixed 29212778 
rs679574 ALPI 19 49206108 C G Mean platelet volume European 27863252 
rs679574 ALPI 19 49206108 C G Total cholesterol European 24097068 
rs679574 ALPI 19 49206108 C G Total cholesterol Mixed 20686565 
rs679574 ALPI 19 49206108 C G Total cholesterol Mixed 20686565 
rs679574 ALPI 19 49206108 C G Crohns disease European 26192919 
rs679574 ALPI 19 49206108 C G Alkaline phosphatase European 28887542 
rs2519093 B3GNT2 9 136141870 C T Granulocyte count European 27863252 
rs2519093 B3GNT2 9 136141870 C T Hematocrit European 27863252 
rs2519093 B3GNT2 9 136141870 C T Hemoglobin concentration European 27863252 
rs2519093 B3GNT2 9 136141870 C T Lymphocyte percentage of white cells European 27863252 
rs2519093 B3GNT2 9 136141870 C T Monocyte count European 27863252 
rs2519093 B3GNT2 9 136141870 C T Myeloid white cell count European 27863252 
rs2519093 B3GNT2 9 136141870 C T Neutrophil count European 27863252 
rs2519093 B3GNT2 9 136141870 C T Platelet distribution width European 27863252 
rs2519093 B3GNT2 9 136141870 C T Red blood cell count European 27863252 
rs2519093 B3GNT2 9 136141870 C T Red cell distribution width European 27863252 
rs2519093 B3GNT2 9 136141870 C T Sum basophil neutrophil counts European 27863252 
rs2519093 B3GNT2 9 136141870 C T Sum eosinophil basophil counts European 27863252 
rs2519093 B3GNT2 9 136141870 C T Sum neutrophil eosinophil counts European 27863252 
rs2519093 B3GNT2 9 136141870 C T White blood cell count European 27863252 
rs2519093 B3GNT2 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 B3GNT2 9 136141870 C T Myocardial infarction Mixed 26343387 
rs2519093 B3GNT2 9 136141870 C T Low density lipoprotein European 24097068 
rs2519093 B3GNT2 9 136141870 C T Total cholesterol European 24097068 
rs2519093 B3GNT2 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 B3GNT2 9 136141870 C T Venous thrombosis European 22675575 
rs2519093 B3GNT2 9 136141870 C T Allergy European 27182965 
rs2519093 B3GNT2 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 B3GNT2 9 136141870 C T Coronary artery disease Mixed 29212778 
rs2519093 B3GNT2 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 B3GNT2 9 136141870 C T Venous thromboembolism European 28373160 
rs2519093 B3GNT2 9 136141870 C T Coronary artery disease Mixed 28714975 
rs2519093 B3GNT2 9 136141870 C T High grade serous ovarian cancer European 28346442 
rs2519093 B3GNT2 9 136141870 C T Invasive ovarian cancer European 28346442 
rs2519093 B3GNT2 9 136141870 C T Serous invasive ovarian cancer European 28346442 
rs2519093 B3GNT2 9 136141870 C T Alkaline phosphatase European 28887542 
rs2519093 B3GNT2 9 136141870 C T Ferritin European 28887542 
rs2519093 B3GNT2 9 136141870 C T Coronary artery disease Mixed 29212778 
rs8176747 BCAM 9 136131315 G C Granulocyte percentage of myeloid white cells European 27863252 
rs8176747 BCAM 9 136131315 G C Hematocrit European 27863252 
rs8176747 BCAM 9 136131315 G C Hemoglobin concentration European 27863252 
rs8176747 BCAM 9 136131315 G C Mean corpuscular hemoglobin European 27863252 
rs8176747 BCAM 9 136131315 G C Mean corpuscular hemoglobin concentration European 27863252 
rs8176747 BCAM 9 136131315 G C Mean corpuscular volume European 27863252 
rs8176747 BCAM 9 136131315 G C Monocyte percentage of white cells European 27863252 
rs8176747 BCAM 9 136131315 G C Neutrophil percentage of white cells European 27863252 
rs8176747 BCAM 9 136131315 G C Platelet count European 27863252 
rs8176747 BCAM 9 136131315 G C Plateletcrit European 27863252 
rs8176747 BCAM 9 136131315 G C Red blood cell count European 27863252 
rs8176747 BCAM 9 136131315 G C Red cell distribution width European 27863252 
rs8176747 BCAM 9 136131315 G C Reticulocyte count European 27863252 
rs8176747 BCAM 9 136131315 G C Activated partial thromboplastin time European 22703881 
rs8176747 BCAM 9 136131315 G C Factor XIII antigen European 23381943 
rs8176747 BCAM 9 136131315 G C Hemoglobin Hb Mixed 23222517 
rs8176747 BCAM 9 136131315 G C Plasma carcinoembryonic antigen CEA levels East Asian 23300138 
rs8176747 BCAM 9 136131315 G C Red blood cell count RBC Mixed 23222517 
rs8176747 BCAM 9 136131315 G C von Willebrand factor vWF European 23381943 
rs8176747 BCAM 9 136131315 G C Platelet count European 27863252 
rs8176747 BCAM 9 136131315 G C Reticulocyte count European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Granulocyte count European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Hematocrit European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Hemoglobin concentration European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Lymphocyte percentage of white cells European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Monocyte count European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Myeloid white cell count European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Neutrophil count European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Platelet distribution width European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Red blood cell count European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Red cell distribution width European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Sum basophil neutrophil counts European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Sum eosinophil basophil counts European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Sum neutrophil eosinophil counts European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T White blood cell count European 27863252 
rs2519093 C1GALT1C1 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 C1GALT1C1 9 136141870 C T Myocardial infarction Mixed 26343387 
rs2519093 C1GALT1C1 9 136141870 C T Low density lipoprotein European 24097068 
rs2519093 C1GALT1C1 9 136141870 C T Total cholesterol European 24097068 
rs2519093 C1GALT1C1 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 C1GALT1C1 9 136141870 C T Venous thrombosis European 22675575 
rs2519093 C1GALT1C1 9 136141870 C T Allergy European 27182965 
rs2519093 C1GALT1C1 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 C1GALT1C1 9 136141870 C T Coronary artery disease Mixed 29212778 
rs2519093 C1GALT1C1 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 C1GALT1C1 9 136141870 C T Venous thromboembolism European 28373160 
rs2519093 C1GALT1C1 9 136141870 C T Coronary artery disease Mixed 28714975 
rs2519093 C1GALT1C1 9 136141870 C T High grade serous ovarian cancer European 28346442 
rs2519093 C1GALT1C1 9 136141870 C T Invasive ovarian cancer European 28346442 
rs2519093 C1GALT1C1 9 136141870 C T Serous invasive ovarian cancer European 28346442 
rs2519093 C1GALT1C1 9 136141870 C T Alkaline phosphatase European 28887542 
rs2519093 C1GALT1C1 9 136141870 C T Ferritin European 28887542 
rs2519093 C1GALT1C1 9 136141870 C T Coronary artery disease Mixed 29212778 
rs4525 CAMK1D 1 169511734 T C Blood protein levels European 28240269 
rs8176693 CD36 9 136137657 T C Granulocyte percentage of myeloid white cells European 27863252 
rs8176693 CD36 9 136137657 T C Hematocrit European 27863252 
rs8176693 CD36 9 136137657 T C Hemoglobin concentration European 27863252 
rs8176693 CD36 9 136137657 T C Mean corpuscular hemoglobin European 27863252 
rs8176693 CD36 9 136137657 T C Mean corpuscular hemoglobin concentration European 27863252 
rs8176693 CD36 9 136137657 T C Mean corpuscular volume European 27863252 
rs8176693 CD36 9 136137657 T C Monocyte percentage of white cells European 27863252 
rs8176693 CD36 9 136137657 T C Neutrophil percentage of white cells European 27863252 
rs8176693 CD36 9 136137657 T C Platelet count European 27863252 
rs8176693 CD36 9 136137657 T C Plateletcrit European 27863252 
rs8176693 CD36 9 136137657 T C Red blood cell count European 27863252 
rs8176693 CD36 9 136137657 T C Red cell distribution width European 27863252 
rs8176693 CD36 9 136137657 T C Reticulocyte count European 27863252 
rs8176693 CD36 9 136137657 T C Low density lipoprotein European 24097068 
rs8176693 CD36 9 136137657 T C Activated partial thromboplastin time European 22703881 
rs8176693 CD36 9 136137657 T C Factor XIII antigen European 23381943 
rs8176693 CD36 9 136137657 T C Hemoglobin Hb Mixed 23222517 
rs8176693 CD36 9 136137657 T C Malaria African 23717212 
rs8176693 CD36 9 136137657 T C Metabolic syndrome domains Multivariate analysis Mixed 22022282 
rs8176693 CD36 9 136137657 T C Plasma carcinoembryonic antigen CEA levels East Asian 23300138 
rs8176693 CD36 9 136137657 T C Red blood cell count RBC Mixed 23222517 
rs8176693 CD36 9 136137657 T C von Willebrand factor vWF European 23381943 
rs8176693 CD36 9 136137657 T C Endothelial growth factor levels European 25552591 
rs8176693 CD36 9 136137657 T C High serum lipase activity European 25028398 
rs8176693 CD36 9 136137657 T C Serum lipase activity European 25028398 
rs8176746 CDH5 9 136131322 T G Granulocyte percentage of myeloid white cells European 27863252 
rs8176746 CDH5 9 136131322 T G Hematocrit European 27863252 
rs8176746 CDH5 9 136131322 T G Hemoglobin concentration European 27863252 
rs8176746 CDH5 9 136131322 T G Mean corpuscular hemoglobin European 27863252 
rs8176746 CDH5 9 136131322 T G Mean corpuscular hemoglobin concentration European 27863252 
rs8176746 CDH5 9 136131322 T G Mean corpuscular volume European 27863252 
rs8176746 CDH5 9 136131322 T G Monocyte percentage of white cells European 27863252 
rs8176746 CDH5 9 136131322 T G Platelet count European 27863252 
rs8176746 CDH5 9 136131322 T G Plateletcrit European 27863252 
rs8176746 CDH5 9 136131322 T G Red blood cell count European 27863252 
rs8176746 CDH5 9 136131322 T G Red cell distribution width European 27863252 
rs8176746 CDH5 9 136131322 T G Reticulocyte count European 27863252 
rs8176746 CDH5 9 136131322 T G Low density lipoprotein European 24097068 
rs8176746 CDH5 9 136131322 T G Activated partial thromboplastin time European 22703881 
rs8176746 CDH5 9 136131322 T G Angiotensin converting enzyme ACE activity East Asian 20066004 
rs8176746 CDH5 9 136131322 T G Factor XIII antigen European 23381943 
rs8176746 CDH5 9 136131322 T G Hemoglobin Hb Mixed 23222517 
rs8176746 CDH5 9 136131322 T G Mean corpuscular hemoglobin concentration East Asian 20139978 
rs8176746 CDH5 9 136131322 T G Plasma carcinoembryonic antigen CEA levels East Asian 23300138 
rs8176746 CDH5 9 136131322 T G Red blood cell count RBC Mixed 23222517 
rs8176746 CDH5 9 136131322 T G TNF alpha TNF a European 18464913 
rs8176746 CDH5 9 136131322 T G von Willebrand factor vWF European 23381943 
rs8176746 CDH5 9 136131322 T G Mean corpuscular hemoglobin concentration East Asian 20139978 
rs8176746 CDH5 9 136131322 T G Mean corpuscular volume Mixed 28017375 
rs550057 CHST15 9 136146597 C T Granulocyte count European 27863252 
rs550057 CHST15 9 136146597 C T Hematocrit European 27863252 
rs550057 CHST15 9 136146597 C T Hemoglobin concentration European 27863252 
rs550057 CHST15 9 136146597 C T Mean corpuscular volume European 27863252 
rs550057 CHST15 9 136146597 C T Monocyte count European 27863252 
rs550057 CHST15 9 136146597 C T Myeloid white cell count European 27863252 
rs550057 CHST15 9 136146597 C T Neutrophil count European 27863252 
rs550057 CHST15 9 136146597 C T Red blood cell count European 27863252 
rs550057 CHST15 9 136146597 C T Red cell distribution width European 27863252 
rs550057 CHST15 9 136146597 C T Sum basophil neutrophil counts European 27863252 
rs550057 CHST15 9 136146597 C T Sum neutrophil eosinophil counts European 27863252 
rs550057 CHST15 9 136146597 C T White blood cell count European 27863252 
rs550057 CHST15 9 136146597 C T Coronary artery disease Mixed 26343387 
rs550057 CHST15 9 136146597 C T Myocardial infarction Mixed 26343387 
rs550057 CHST15 9 136146597 C T Venous thrombosis European 22675575 
rs550057 CHST15 9 136146597 C T LDL cholesterol European 25961943 
rs550057 CHST15 9 136146597 C T High grade serous ovarian cancer European 28346442 
rs550057 CHST15 9 136146597 C T Serous invasive ovarian cancer European 28346442 
rs550057 CHST15 9 136146597 C T Alkaline phosphatase European 28887542 
rs550057 CHST15 9 136146597 C T Ferritin European 28887542 
rs550057 CHST15 9 136146597 C T Coronary artery disease Mixed 29212778 
rs62143206 CPNE1 19 54326212 G T Granulocyte percentage of myeloid white cells European 27863252 
rs62143206 CPNE1 19 54326212 G T Monocyte count European 27863252 
rs62143206 CPNE1 19 54326212 G T Monocyte percentage of white cells European 27863252 
rs62143206 CPNE1 19 54326212 G T Granulocyte percentage of myeloid white cells European 27863252 
rs62143206 CPNE1 19 54326212 G T Monocyte percentage of white cells European 27863252 
rs12481228 CPNE1 20 34218673 C G Height European 28146470 
rs12481228 CPNE1 20 34218673 C G Height Mixed 28146470 
rs3197999 CRYBB2 3 49721532 G A High light scatter percentage of red cells European 27863252 
rs3197999 CRYBB2 3 49721532 G A High light scatter reticulocyte count European 27863252 
rs3197999 CRYBB2 3 49721532 G A Immature fraction of reticulocytes European 27863252 
rs3197999 CRYBB2 3 49721532 G A Reticulocyte count European 27863252 
rs3197999 CRYBB2 3 49721532 G A Reticulocyte fraction of red cells European 27863252 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 18587394 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 19915574 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 21102463 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 21150878 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 21297633 
rs3197999 CRYBB2 3 49721532 G A Inflammatory bowel disease European 23128233 
rs3197999 CRYBB2 3 49721532 G A Irritable bowel disorder European 19915574 
rs3197999 CRYBB2 3 49721532 G A Primary sclerosing cholangitis European 21151127 
rs3197999 CRYBB2 3 49721532 G A Primary sclerosing cholangitis European 23603763 
rs3197999 CRYBB2 3 49721532 G A Selective immunoglobulin A deficiency IgAD European 20694011 
rs3197999 CRYBB2 3 49721532 G A Ulcerative colitis European 20228799 
rs3197999 CRYBB2 3 49721532 G A Ulcerative colitis European 21297633 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 23128233 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 26192919 
rs3197999 CRYBB2 3 49721532 G A Inflammatory bowel disease European 26192919 
rs3197999 CRYBB2 3 49721532 G A Ulcerative colitis European 23128233 
rs3197999 CRYBB2 3 49721532 G A Ulcerative colitis European 26192919 
rs3197999 CRYBB2 3 49721532 G A Primary sclerosing cholangitis European 27992413 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 18587394 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 21102463 
rs3197999 CRYBB2 3 49721532 G A Crohns disease European 26192919 
rs3197999 CRYBB2 3 49721532 G A Crohns disease Mixed 28067908 
rs3197999 CRYBB2 3 49721532 G A Inflammatory bowel disease European 23128233 
rs3197999 CRYBB2 3 49721532 G A Inflammatory bowel disease Mixed 28067908 
rs3197999 CRYBB2 3 49721532 G A Primary sclerosing cholangitis European 21151127 
rs3197999 CRYBB2 3 49721532 G A Primary sclerosing cholangitis European 27992413 
rs3197999 CRYBB2 3 49721532 G A Ulcerative colitis European 20228799 
rs3197999 CRYBB2 3 49721532 G A Ulcerative colitis European 26192919 
rs3197999 CRYBB2 3 49721532 G A Ulcerative colitis Mixed 28067908 
rs3197999 CRYBB2 3 49721532 G A Age at menarche European 25231870 
rs3197999 CRYBB2 3 49721532 G A Years of educational attainment in females European 27225129 
rs3197999 CRYBB2 3 49721532 G A Years of educational attainment in males European 27225129 
rs3197999 CRYBB2 3 49721532 G A Years of educational attainment European 27225129 
rs3197999 CRYBB2 3 49721532 G A Cholangitis sclerosing European 21151127 
rs3197999 CRYBB2 3 49721532 G A Colitis ulcerative European 20228799 
rs3197999 CRYBB2 3 49721532 G A Crohn disease European 18587394 
rs3197999 DOCK9 3 49721532 G A High light scatter percentage of red cells European 27863252 
rs3197999 DOCK9 3 49721532 G A High light scatter reticulocyte count European 27863252 
rs3197999 DOCK9 3 49721532 G A Immature fraction of reticulocytes European 27863252 
rs3197999 DOCK9 3 49721532 G A Reticulocyte count European 27863252 
rs3197999 DOCK9 3 49721532 G A Reticulocyte fraction of red cells European 27863252 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 18587394 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 19915574 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 21102463 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 21150878 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 21297633 
rs3197999 DOCK9 3 49721532 G A Inflammatory bowel disease European 23128233 
rs3197999 DOCK9 3 49721532 G A Irritable bowel disorder European 19915574 
rs3197999 DOCK9 3 49721532 G A Primary sclerosing cholangitis European 21151127 
rs3197999 DOCK9 3 49721532 G A Primary sclerosing cholangitis European 23603763 
rs3197999 DOCK9 3 49721532 G A Selective immunoglobulin A deficiency IgAD European 20694011 
rs3197999 DOCK9 3 49721532 G A Ulcerative colitis European 20228799 
rs3197999 DOCK9 3 49721532 G A Ulcerative colitis European 21297633 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 23128233 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 26192919 
rs3197999 DOCK9 3 49721532 G A Inflammatory bowel disease European 26192919 
rs3197999 DOCK9 3 49721532 G A Ulcerative colitis European 23128233 
rs3197999 DOCK9 3 49721532 G A Ulcerative colitis European 26192919 
rs3197999 DOCK9 3 49721532 G A Primary sclerosing cholangitis European 27992413 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 18587394 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 21102463 
rs3197999 DOCK9 3 49721532 G A Crohns disease European 26192919 
rs3197999 DOCK9 3 49721532 G A Crohns disease Mixed 28067908 
rs3197999 DOCK9 3 49721532 G A Inflammatory bowel disease European 23128233 
rs3197999 DOCK9 3 49721532 G A Inflammatory bowel disease Mixed 28067908 
rs3197999 DOCK9 3 49721532 G A Primary sclerosing cholangitis European 21151127 
rs3197999 DOCK9 3 49721532 G A Primary sclerosing cholangitis European 27992413 
rs3197999 DOCK9 3 49721532 G A Ulcerative colitis European 20228799 
rs3197999 DOCK9 3 49721532 G A Ulcerative colitis European 26192919 
rs3197999 DOCK9 3 49721532 G A Ulcerative colitis Mixed 28067908 
rs3197999 DOCK9 3 49721532 G A Age at menarche European 25231870 
rs3197999 DOCK9 3 49721532 G A Years of educational attainment in females European 27225129 
rs3197999 DOCK9 3 49721532 G A Years of educational attainment in males European 27225129 
rs3197999 DOCK9 3 49721532 G A Years of educational attainment European 27225129 
rs3197999 DOCK9 3 49721532 G A Cholangitis sclerosing European 21151127 
rs3197999 DOCK9 3 49721532 G A Colitis ulcerative European 20228799 
rs3197999 DOCK9 3 49721532 G A Crohn disease European 18587394 
rs635634 ENG 9 136155000 T C Granulocyte count European 27863252 
rs635634 ENG 9 136155000 T C Hematocrit European 27863252 
rs635634 ENG 9 136155000 T C Hemoglobin concentration European 27863252 
rs635634 ENG 9 136155000 T C Lymphocyte percentage of white cells European 27863252 
rs635634 ENG 9 136155000 T C Monocyte count European 27863252 
rs635634 ENG 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 ENG 9 136155000 T C Neutrophil count European 27863252 
rs635634 ENG 9 136155000 T C Platelet distribution width European 27863252 
rs635634 ENG 9 136155000 T C Red blood cell count European 27863252 
rs635634 ENG 9 136155000 T C Red cell distribution width European 27863252 
rs635634 ENG 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 ENG 9 136155000 T C Sum eosinophil basophil counts European 27863252 
rs635634 ENG 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 ENG 9 136155000 T C White blood cell count European 27863252 
rs635634 ENG 9 136155000 T C Coronary artery disease Mixed 26343387 
rs635634 ENG 9 136155000 T C Myocardial infarction Mixed 26343387 
rs635634 ENG 9 136155000 T C Low density lipoprotein European 24097068 
rs635634 ENG 9 136155000 T C Low density lipoprotein Mixed 20686565 
rs635634 ENG 9 136155000 T C Total cholesterol European 24097068 
rs635634 ENG 9 136155000 T C Total cholesterol Mixed 20686565 
rs635634 ENG 9 136155000 T C Circulating galectin 3 levels European 23056639 
rs635634 ENG 9 136155000 T C Venous thrombosis European 22675575 
rs635634 ENG 9 136155000 T C Cholesterol total Mixed 20686565 
rs635634 ENG 9 136155000 T C Cholesterol total European 24097068 
rs635634 ENG 9 136155000 T C GIP levels in response to oral glucose tolerance test 120 minutes European 29093273 
rs635634 ENG 9 136155000 T C Granulocyte count European 27863252 
rs635634 ENG 9 136155000 T C Ischemic stroke European 27997041 
rs635634 ENG 9 136155000 T C LDL cholesterol Mixed 20686565 
rs635634 ENG 9 136155000 T C LDL cholesterol European 24097068 
rs635634 ENG 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 ENG 9 136155000 T C Neutrophil count European 27863252 
rs635634 ENG 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 ENG 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 ENG 9 136155000 T C Tonsillectomy European 27182965 
rs635634 ENG 9 136155000 T C Tonsillectomy European 28928442 
rs635634 ENG 9 136155000 T C Type 2 diabetes European 28566273 
rs635634 ENG 9 136155000 T C White blood cell count European 27863252 
rs635634 ENG 9 136155000 T C Coronary artery disease Mixed 28714975 
rs635634 ENG 9 136155000 T C High grade serous ovarian cancer European 28346442 
rs635634 ENG 9 136155000 T C Invasive ovarian cancer European 28346442 
rs635634 ENG 9 136155000 T C Serous invasive ovarian cancer European 28346442 
rs635634 ENG 9 136155000 T C Alkaline phosphatase European 28887542 
rs635634 ENG 9 136155000 T C Ferritin European 28887542 
rs635634 ENG 9 136155000 T C Coronary artery disease Mixed 29212778 
rs550057 FAM177A1 9 136146597 C T Granulocyte count European 27863252 
rs550057 FAM177A1 9 136146597 C T Hematocrit European 27863252 
rs550057 FAM177A1 9 136146597 C T Hemoglobin concentration European 27863252 
rs550057 FAM177A1 9 136146597 C T Mean corpuscular volume European 27863252 
rs550057 FAM177A1 9 136146597 C T Monocyte count European 27863252 
rs550057 FAM177A1 9 136146597 C T Myeloid white cell count European 27863252 
rs550057 FAM177A1 9 136146597 C T Neutrophil count European 27863252 
rs550057 FAM177A1 9 136146597 C T Red blood cell count European 27863252 
rs550057 FAM177A1 9 136146597 C T Red cell distribution width European 27863252 
rs550057 FAM177A1 9 136146597 C T Sum basophil neutrophil counts European 27863252 
rs550057 FAM177A1 9 136146597 C T Sum neutrophil eosinophil counts European 27863252 
rs550057 FAM177A1 9 136146597 C T White blood cell count European 27863252 
rs550057 FAM177A1 9 136146597 C T Coronary artery disease Mixed 26343387 
rs550057 FAM177A1 9 136146597 C T Myocardial infarction Mixed 26343387 
rs550057 FAM177A1 9 136146597 C T Venous thrombosis European 22675575 
rs550057 FAM177A1 9 136146597 C T LDL cholesterol European 25961943 
rs550057 FAM177A1 9 136146597 C T High grade serous ovarian cancer European 28346442 
rs550057 FAM177A1 9 136146597 C T Serous invasive ovarian cancer European 28346442 
rs550057 FAM177A1 9 136146597 C T Alkaline phosphatase European 28887542 
rs550057 FAM177A1 9 136146597 C T Ferritin European 28887542 
rs550057 FAM177A1 9 136146597 C T Coronary artery disease Mixed 29212778 
rs679574 FAM177A1 19 49206108 C G Mean platelet volume European 27863252 
rs679574 FAM177A1 19 49206108 C G Total cholesterol European 24097068 
rs679574 FAM177A1 19 49206108 C G Total cholesterol Mixed 20686565 
rs679574 FAM177A1 19 49206108 C G Total cholesterol Mixed 20686565 
rs679574 FAM177A1 19 49206108 C G Crohns disease European 26192919 
rs679574 FAM177A1 19 49206108 C G Alkaline phosphatase European 28887542 
rs371314787 FASLG (soluble) 3 49709912 - T High light scatter percentage of red cells European 27863252 
rs371314787 FASLG (soluble) 3 49709912 - T High light scatter reticulocyte count European 27863252 
rs371314787 FASLG (soluble) 3 49709912 - T Immature fraction of reticulocytes European 27863252 
rs371314787 FASLG (soluble) 3 49709912 - T Mean corpuscular volume European 27863252 
rs371314787 FASLG (soluble) 3 49709912 - T Reticulocyte count European 27863252 
rs371314787 FASLG (soluble) 3 49709912 - T Reticulocyte fraction of red cells European 27863252 
rs601338 GOLM1 19 49206674 A G Mean platelet volume European 27863252 
rs601338 GOLM1 19 49206674 A G Total cholesterol European 24097068 
rs601338 GOLM1 19 49206674 A G Total cholesterol Mixed 20686565 
rs601338 GOLM1 19 49206674 A G Alkaline phosphatase ALP in plasma Mixed 22001757 
rs601338 GOLM1 19 49206674 A G Gamma glutamyl transferase Mixed 22001757 
rs601338 GOLM1 19 49206674 A G Total cholesterol Mixed 20686565 
rs601338 GOLM1 19 49206674 A G Vitamin B12 female European 18776911 
rs601338 GOLM1 19 49206674 A G Crohns disease European 23128233 
rs601338 GOLM1 19 49206674 A G Crohns disease European 26192919 
rs601338 GOLM1 19 49206674 A G Blood metabolite levels European 24816252 
rs601338 GOLM1 19 49206674 A G Blood metabolite ratios European 24816252 
rs601338 GOLM1 19 49206674 A G Alkaline phosphatase European 28887542 
rs635634 IGFIR (soluble) 9 136155000 T C Granulocyte count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Hematocrit European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Hemoglobin concentration European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Lymphocyte percentage of white cells European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Monocyte count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Neutrophil count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Platelet distribution width European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Red blood cell count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Red cell distribution width European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Sum eosinophil basophil counts European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C White blood cell count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Coronary artery disease Mixed 26343387 
rs635634 IGFIR (soluble) 9 136155000 T C Myocardial infarction Mixed 26343387 
rs635634 IGFIR (soluble) 9 136155000 T C Low density lipoprotein European 24097068 
rs635634 IGFIR (soluble) 9 136155000 T C Low density lipoprotein Mixed 20686565 
rs635634 IGFIR (soluble) 9 136155000 T C Total cholesterol European 24097068 
rs635634 IGFIR (soluble) 9 136155000 T C Total cholesterol Mixed 20686565 
rs635634 IGFIR (soluble) 9 136155000 T C Circulating galectin 3 levels European 23056639 
rs635634 IGFIR (soluble) 9 136155000 T C Venous thrombosis European 22675575 
rs635634 IGFIR (soluble) 9 136155000 T C Cholesterol total Mixed 20686565 
rs635634 IGFIR (soluble) 9 136155000 T C Cholesterol total European 24097068 
rs635634 IGFIR (soluble) 9 136155000 T C GIP levels in response to oral glucose tolerance test 120 minutes European 29093273 
rs635634 IGFIR (soluble) 9 136155000 T C Granulocyte count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Ischemic stroke European 27997041 
rs635634 IGFIR (soluble) 9 136155000 T C LDL cholesterol Mixed 20686565 
rs635634 IGFIR (soluble) 9 136155000 T C LDL cholesterol European 24097068 
rs635634 IGFIR (soluble) 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Neutrophil count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Tonsillectomy European 27182965 
rs635634 IGFIR (soluble) 9 136155000 T C Tonsillectomy European 28928442 
rs635634 IGFIR (soluble) 9 136155000 T C Type 2 diabetes European 28566273 
rs635634 IGFIR (soluble) 9 136155000 T C White blood cell count European 27863252 
rs635634 IGFIR (soluble) 9 136155000 T C Coronary artery disease Mixed 28714975 
rs635634 IGFIR (soluble) 9 136155000 T C High grade serous ovarian cancer European 28346442 
rs635634 IGFIR (soluble) 9 136155000 T C Invasive ovarian cancer European 28346442 
rs635634 IGFIR (soluble) 9 136155000 T C Serous invasive ovarian cancer European 28346442 
rs635634 IGFIR (soluble) 9 136155000 T C Alkaline phosphatase European 28887542 
rs635634 IGFIR (soluble) 9 136155000 T C Ferritin European 28887542 
rs635634 IGFIR (soluble) 9 136155000 T C Coronary artery disease Mixed 29212778 
rs2519093 IL3RA 9 136141870 C T Granulocyte count European 27863252 
rs2519093 IL3RA 9 136141870 C T Hematocrit European 27863252 
rs2519093 IL3RA 9 136141870 C T Hemoglobin concentration European 27863252 
rs2519093 IL3RA 9 136141870 C T Lymphocyte percentage of white cells European 27863252 
rs2519093 IL3RA 9 136141870 C T Monocyte count European 27863252 
rs2519093 IL3RA 9 136141870 C T Myeloid white cell count European 27863252 
rs2519093 IL3RA 9 136141870 C T Neutrophil count European 27863252 
rs2519093 IL3RA 9 136141870 C T Platelet distribution width European 27863252 
rs2519093 IL3RA 9 136141870 C T Red blood cell count European 27863252 
rs2519093 IL3RA 9 136141870 C T Red cell distribution width European 27863252 
rs2519093 IL3RA 9 136141870 C T Sum basophil neutrophil counts European 27863252 
rs2519093 IL3RA 9 136141870 C T Sum eosinophil basophil counts European 27863252 
rs2519093 IL3RA 9 136141870 C T Sum neutrophil eosinophil counts European 27863252 
rs2519093 IL3RA 9 136141870 C T White blood cell count European 27863252 
rs2519093 IL3RA 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 IL3RA 9 136141870 C T Myocardial infarction Mixed 26343387 
rs2519093 IL3RA 9 136141870 C T Low density lipoprotein European 24097068 
rs2519093 IL3RA 9 136141870 C T Total cholesterol European 24097068 
rs2519093 IL3RA 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 IL3RA 9 136141870 C T Venous thrombosis European 22675575 
rs2519093 IL3RA 9 136141870 C T Allergy European 27182965 
rs2519093 IL3RA 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 IL3RA 9 136141870 C T Coronary artery disease Mixed 29212778 
rs2519093 IL3RA 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 IL3RA 9 136141870 C T Venous thromboembolism European 28373160 
rs2519093 IL3RA 9 136141870 C T Coronary artery disease Mixed 28714975 
rs2519093 IL3RA 9 136141870 C T High grade serous ovarian cancer European 28346442 
rs2519093 IL3RA 9 136141870 C T Invasive ovarian cancer European 28346442 
rs2519093 IL3RA 9 136141870 C T Serous invasive ovarian cancer European 28346442 
rs2519093 IL3RA 9 136141870 C T Alkaline phosphatase European 28887542 
rs2519093 IL3RA 9 136141870 C T Ferritin European 28887542 
rs2519093 IL3RA 9 136141870 C T Coronary artery disease Mixed 29212778 
rs507666 IR 9 136149399 A G Granulocyte count European 27863252 
rs507666 IR 9 136149399 A G Hematocrit European 27863252 
rs507666 IR 9 136149399 A G Hemoglobin concentration European 27863252 
rs507666 IR 9 136149399 A G Lymphocyte percentage of white cells European 27863252 
rs507666 IR 9 136149399 A G Monocyte count European 27863252 
rs507666 IR 9 136149399 A G Myeloid white cell count European 27863252 
rs507666 IR 9 136149399 A G Neutrophil count European 27863252 
rs507666 IR 9 136149399 A G Platelet distribution width European 27863252 
rs507666 IR 9 136149399 A G Red blood cell count European 27863252 
rs507666 IR 9 136149399 A G Red cell distribution width European 27863252 
rs507666 IR 9 136149399 A G Sum basophil neutrophil counts European 27863252 
rs507666 IR 9 136149399 A G Sum eosinophil basophil counts European 27863252 
rs507666 IR 9 136149399 A G Sum neutrophil eosinophil counts European 27863252 
rs507666 IR 9 136149399 A G White blood cell count European 27863252 
rs507666 IR 9 136149399 A G Coronary artery disease Mixed 26343387 
rs507666 IR 9 136149399 A G Myocardial infarction Mixed 26343387 
rs507666 IR 9 136149399 A G Low density lipoprotein European 24097068 
rs507666 IR 9 136149399 A G Total cholesterol European 24097068 
rs507666 IR 9 136149399 A G LDL cholesterol large lipoprotein fraction concentration European 19936222 
rs507666 IR 9 136149399 A G LDL cholesterol lipoprotein fraction concentration European 19936222 
rs507666 IR 9 136149399 A G LDL cholesterol lipoprotein fraction concentration in fasting sample European 19936222 
rs507666 IR 9 136149399 A G Plasma carcinoembryonic antigen CEA levels East Asian 23300138 
rs507666 IR 9 136149399 A G Plasma soluble intercellular adhesion molecule 1 ICAM 1 females European 18604267 
rs507666 IR 9 136149399 A G Soluble intercellular adhesion molecule 1 ICAM 1 European 21533024 
rs507666 IR 9 136149399 A G VLDL cholesterol mean size lipoprotein fraction concentration European 19936222 
rs507666 IR 9 136149399 A G VLDL cholesterol small lipoprotein fraction concentration European 19936222 
rs507666 IR 9 136149399 A G VLDL cholesterol small lipoprotein fraction concentration in fasting sample European 19936222 
rs507666 IR 9 136149399 A G Venous thrombosis European 22675575 
rs507666 IR 9 136149399 A G Blood protein levels European 28240269 
rs507666 IR 9 136149399 A G Cholesterol total European 25961943 
rs507666 IR 9 136149399 A G Coronary artery disease Mixed 28714975 
rs507666 IR 9 136149399 A G Coronary artery disease Mixed 29212778 
rs507666 IR 9 136149399 A G Lipid traits East Asian 24386095 
rs507666 IR 9 136149399 A G Lipid traits East Asian 24386095 
rs507666 IR 9 136149399 A G Soluble ICAM 1 European 18604267 
rs507666 IR 9 136149399 A G Soluble ICAM 1 European 21533024 
rs507666 IR 9 136149399 A G Coronary artery disease Mixed 28714975 
rs507666 IR 9 136149399 A G High grade serous ovarian cancer European 28346442 
rs507666 IR 9 136149399 A G Invasive ovarian cancer European 28346442 
rs507666 IR 9 136149399 A G Serous invasive ovarian cancer European 28346442 
rs507666 IR 9 136149399 A G Alkaline phosphatase European 28887542 
rs507666 IR 9 136149399 A G Ferritin European 28887542 
rs507666 IR 9 136149399 A G Intercellular adhesion molecule 1 European 18604267 
rs507666 IR 9 136149399 A G Intercellular adhesion molecule 1 European 21533024 
rs507666 IR 9 136149399 A G Coronary artery disease Mixed 29212778 
rs115478735 ISLR2 9 136149711 A T Granulocyte count European 27863252 
rs115478735 ISLR2 9 136149711 A T Hematocrit European 27863252 
rs115478735 ISLR2 9 136149711 A T Hemoglobin concentration European 27863252 
rs115478735 ISLR2 9 136149711 A T Lymphocyte percentage of white cells European 27863252 
rs115478735 ISLR2 9 136149711 A T Monocyte count European 27863252 
rs115478735 ISLR2 9 136149711 A T Myeloid white cell count European 27863252 
rs115478735 ISLR2 9 136149711 A T Neutrophil count European 27863252 
rs115478735 ISLR2 9 136149711 A T Platelet distribution width European 27863252 
rs115478735 ISLR2 9 136149711 A T Red blood cell count European 27863252 
rs115478735 ISLR2 9 136149711 A T Red cell distribution width European 27863252 
rs115478735 ISLR2 9 136149711 A T Sum basophil neutrophil counts European 27863252 
rs115478735 ISLR2 9 136149711 A T Sum eosinophil basophil counts European 27863252 
rs115478735 ISLR2 9 136149711 A T Sum neutrophil eosinophil counts European 27863252 
rs115478735 ISLR2 9 136149711 A T White blood cell count European 27863252 
rs115478735 ISLR2 9 136149711 A T High grade serous ovarian cancer European 28346442 
rs115478735 ISLR2 9 136149711 A T Invasive ovarian cancer European 28346442 
rs115478735 ISLR2 9 136149711 A T Serous invasive ovarian cancer European 28346442 
rs7041 JAG1 4 72618334 C A 25 hydroxy vitamin D concentrations European 20541252 
rs7041 JAG1 4 72618334 C A Circulating 25OHD vitamin D levels European 20418485 
rs7041 JAG1 4 72618334 C A Serum vitamin D binding protein levels European 24740207 
rs550057 JAG1 9 136146597 C T Granulocyte count European 27863252 
rs550057 JAG1 9 136146597 C T Hematocrit European 27863252 
rs550057 JAG1 9 136146597 C T Hemoglobin concentration European 27863252 
rs550057 JAG1 9 136146597 C T Mean corpuscular volume European 27863252 
rs550057 JAG1 9 136146597 C T Monocyte count European 27863252 
rs550057 JAG1 9 136146597 C T Myeloid white cell count European 27863252 
rs550057 JAG1 9 136146597 C T Neutrophil count European 27863252 
rs550057 JAG1 9 136146597 C T Red blood cell count European 27863252 
rs550057 JAG1 9 136146597 C T Red cell distribution width European 27863252 
rs550057 JAG1 9 136146597 C T Sum basophil neutrophil counts European 27863252 
rs550057 JAG1 9 136146597 C T Sum neutrophil eosinophil counts European 27863252 
rs550057 JAG1 9 136146597 C T White blood cell count European 27863252 
rs550057 JAG1 9 136146597 C T Coronary artery disease Mixed 26343387 
rs550057 JAG1 9 136146597 C T Myocardial infarction Mixed 26343387 
rs550057 JAG1 9 136146597 C T Venous thrombosis European 22675575 
rs550057 JAG1 9 136146597 C T LDL cholesterol European 25961943 
rs550057 JAG1 9 136146597 C T High grade serous ovarian cancer European 28346442 
rs550057 JAG1 9 136146597 C T Serous invasive ovarian cancer European 28346442 
rs550057 JAG1 9 136146597 C T Alkaline phosphatase European 28887542 
rs550057 JAG1 9 136146597 C T Ferritin European 28887542 
rs550057 JAG1 9 136146597 C T Coronary artery disease Mixed 29212778 
rs7412 KIN 19 45412079 C T High light scatter percentage of red cells European 27863252 
rs7412 KIN 19 45412079 C T High light scatter reticulocyte count European 27863252 
rs7412 KIN 19 45412079 C T Immature fraction of reticulocytes European 27863252 
rs7412 KIN 19 45412079 C T Red cell distribution width European 27863252 
rs7412 KIN 19 45412079 C T Reticulocyte count European 27863252 
rs7412 KIN 19 45412079 C T Reticulocyte fraction of red cells European 27863252 
rs7412 KIN 19 45412079 C T Coronary artery disease Mixed 26343387 
rs7412 KIN 19 45412079 C T High density lipoprotein European 24097068 
rs7412 KIN 19 45412079 C T Total cholesterol European 24097068 
rs7412 KIN 19 45412079 C T Triglycerides European 24097068 
rs7412 KIN 19 45412079 C T APOB apolipoprotein B European 23100282 
rs7412 KIN 19 45412079 C T APOB apolipoprotein B response after 40mg daily simvastatin treatment European 23100282 
rs7412 KIN 19 45412079 C T LDL cholesterol European 20838585 
rs7412 KIN 19 45412079 C T LDL cholesterol European 23063622 
rs7412 KIN 19 45412079 C T LDL cholesterol African 23067351 
rs7412 KIN 19 45412079 C T LDL cholesterol European 23100282 
rs7412 KIN 19 45412079 C T 
LDL cholesterol among a group where cancer diabetes 
hyper/hypothyroidism and LDL altering medications were not present 
African 23067351 
rs7412 KIN 19 45412079 C T LDL cholesterol change with statins Mixed 20031582 
rs7412 KIN 19 45412079 C T LDL cholesterol response after 40mg daily simvastatin treatment European 23100282 
rs7412 KIN 19 45412079 C T LDL cholesterol response to statins baseline LDL cholesterol European 22331829 
rs7412 KIN 19 45412079 C T LDL cholesterol response to statins fractional change in LDL cholesterol European 22331829 
rs7412 KIN 19 45412079 C T 
LDL cholesterol response to statins residuals of the measure of fractional 
change in LDL cholesterol 
European 22331829 
rs7412 KIN 19 45412079 C T Late onset Alzheimers disease Unspecified 20885792 
rs7412 KIN 19 45412079 C T Late onset Alzheimers disease European 21390209 
rs7412 KIN 19 45412079 C T Lipoprotein associated phospholipase A2 activity Lp2 European 23118302 
rs7412 KIN 19 45412079 C T Total cholesterol European 23063622 
rs7412 KIN 19 45412079 C T Alzheimers disease European 24162737 
rs7412 KIN 19 45412079 C T Cholesterol total European 25961943 
rs7412 KIN 19 45412079 C T Cholesterol total European 28270201 
rs7412 KIN 19 45412079 C T Coronary artery disease Mixed 28714975 
rs7412 KIN 19 45412079 C T Coronary artery disease Mixed 29212778 
rs7412 KIN 19 45412079 C T Coronary artery disease Mixed 29212778 
rs7412 KIN 19 45412079 C T Coronary artery disease Mixed 29212778 
rs7412 KIN 19 45412079 C T HDL cholesterol European 28270201 
rs7412 KIN 19 45412079 C T High light scatter reticulocyte count European 27863252 
rs7412 KIN 19 45412079 C T High light scatter reticulocyte percentage of red cells European 27863252 
rs7412 KIN 19 45412079 C T Ideal cardiovascular health clinical and behavioral European 27179730 
rs7412 KIN 19 45412079 C T Immature fraction of reticulocytes European 27863252 
rs7412 KIN 19 45412079 C T LDL cholesterol African 23067351 
rs7412 KIN 19 45412079 C T LDL cholesterol levels East Asian 28334899 
rs7412 KIN 19 45412079 C T LDL cholesterol levels East Asian 28371326 
rs7412 KIN 19 45412079 C T Lipid metabolism phenotypes European 22286219 
rs7412 KIN 19 45412079 C T Lipid traits Filipino 24023260 
rs7412 KIN 19 45412079 C T Lipid traits Filipino 24023260 
rs7412 KIN 19 45412079 C T Lipoprotein a levels European 28512139 
rs7412 KIN 19 45412079 C T 
Lipoprotein associated phospholipase A2 activity change in response to 
darapladib treatment in cardiovascular disease 
Mixed 28753643 
rs7412 KIN 19 45412079 C T Lipoprotein phospholipase A2 activity in cardiovascular disease Mixed 28753643 
rs7412 KIN 19 45412079 C T Lipoproteina levels adjusted for apolipoproteina isoforms European 28512139 
rs7412 KIN 19 45412079 C T Low density lipoprotein cholesterol Mixed 28548082 
rs7412 KIN 19 45412079 C T Metabolite levels lipoprotein measures European 27005778 
rs7412 KIN 19 45412079 C T Pulse pressure European 28135244 
rs7412 KIN 19 45412079 C T Red cell distribution width European 27863252 
rs7412 KIN 19 45412079 C T Response to statin therapy LDL C European 22331829 
rs7412 KIN 19 45412079 C T Reticulocyte count European 27863252 
rs7412 KIN 19 45412079 C T Reticulocyte fraction of red cells European 27863252 
rs7412 KIN 19 45412079 C T Total cholesterol levels Mixed 28548082 
rs7412 KIN 19 45412079 C T Coronary artery disease Mixed 28714975 
rs7412 KIN 19 45412079 C T Low density lipoprotein European 28887542 
rs7412 KIN 19 45412079 C T Total cholesterol European 28887542 
rs7412 KIN 19 45412079 C T High density lipoprotein East Asian 28334899 
rs7412 KIN 19 45412079 C T Low density lipoprotein East Asian 28334899 
rs7412 KIN 19 45412079 C T Total cholesterol East Asian 28334899 
rs7412 KIN 19 45412079 C T Cholesterol ldl European 22331829 
rs7412 KIN 19 45412079 C T Lipid metabolism European 22286219 
rs7412 KIN 19 45412079 C T Coronary artery disease Mixed 29212778 
rs7412 KIN 19 45412079 C T Coronary artery disease Mixed 29212778 
rs62143198 KIN 19 54320939 A G Granulocyte percentage of myeloid white cells European 27863252 
rs62143198 KIN 19 54320939 A G Monocyte count European 27863252 
rs62143198 KIN 19 54320939 A G Monocyte percentage of white cells European 27863252 
rs11708955 KLRF1 3 49540114 C T High light scatter percentage of red cells European 27863252 
rs11708955 KLRF1 3 49540114 C T High light scatter reticulocyte count European 27863252 
rs11708955 KLRF1 3 49540114 C T Immature fraction of reticulocytes European 27863252 
rs11708955 KLRF1 3 49540114 C T Mean corpuscular volume European 27863252 
rs11708955 KLRF1 3 49540114 C T Reticulocyte count European 27863252 
rs11708955 KLRF1 3 49540114 C T Reticulocyte fraction of red cells European 27863252 
rs11708955 KLRF1 3 49540114 C T Crohns disease European 26192919 
rs11708955 KLRF1 3 49540114 C T Inflammatory bowel disease European 26192919 
rs11708955 KLRF1 3 49540114 C T Ulcerative colitis European 26192919 
rs11708955 KLRF1 3 49540114 C T Primary sclerosing cholangitis European 27992413 
rs11708955 KLRF1 3 49540114 C T Years of educational attainment in females European 27225129 
rs11708955 KLRF1 3 49540114 C T Years of educational attainment in males European 27225129 
rs11708955 KLRF1 3 49540114 C T Years of educational attainment European 27225129 
rs62143194 KLRF1 19 54319624 C G Granulocyte percentage of myeloid white cells European 27863252 
rs62143194 KLRF1 19 54319624 C G Monocyte count European 27863252 
rs62143194 KLRF1 19 54319624 C G Monocyte percentage of white cells European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Granulocyte count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Hematocrit European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Hemoglobin concentration European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Lymphocyte percentage of white cells European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Monocyte count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Neutrophil count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Platelet distribution width European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Red blood cell count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Red cell distribution width European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Sum eosinophil basophil counts European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C White blood cell count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Coronary artery disease Mixed 26343387 
rs635634 LIFR (soluble) 9 136155000 T C Myocardial infarction Mixed 26343387 
rs635634 LIFR (soluble) 9 136155000 T C Low density lipoprotein European 24097068 
rs635634 LIFR (soluble) 9 136155000 T C Low density lipoprotein Mixed 20686565 
rs635634 LIFR (soluble) 9 136155000 T C Total cholesterol European 24097068 
rs635634 LIFR (soluble) 9 136155000 T C Total cholesterol Mixed 20686565 
rs635634 LIFR (soluble) 9 136155000 T C Circulating galectin 3 levels European 23056639 
rs635634 LIFR (soluble) 9 136155000 T C Venous thrombosis European 22675575 
rs635634 LIFR (soluble) 9 136155000 T C Cholesterol total Mixed 20686565 
rs635634 LIFR (soluble) 9 136155000 T C Cholesterol total European 24097068 
rs635634 LIFR (soluble) 9 136155000 T C GIP levels in response to oral glucose tolerance test 120 minutes European 29093273 
rs635634 LIFR (soluble) 9 136155000 T C Granulocyte count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Ischemic stroke European 27997041 
rs635634 LIFR (soluble) 9 136155000 T C LDL cholesterol Mixed 20686565 
rs635634 LIFR (soluble) 9 136155000 T C LDL cholesterol European 24097068 
rs635634 LIFR (soluble) 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Neutrophil count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Tonsillectomy European 27182965 
rs635634 LIFR (soluble) 9 136155000 T C Tonsillectomy European 28928442 
rs635634 LIFR (soluble) 9 136155000 T C Type 2 diabetes European 28566273 
rs635634 LIFR (soluble) 9 136155000 T C White blood cell count European 27863252 
rs635634 LIFR (soluble) 9 136155000 T C Coronary artery disease Mixed 28714975 
rs635634 LIFR (soluble) 9 136155000 T C High grade serous ovarian cancer European 28346442 
rs635634 LIFR (soluble) 9 136155000 T C Invasive ovarian cancer European 28346442 
rs635634 LIFR (soluble) 9 136155000 T C Serous invasive ovarian cancer European 28346442 
rs635634 LIFR (soluble) 9 136155000 T C Alkaline phosphatase European 28887542 
rs635634 LIFR (soluble) 9 136155000 T C Ferritin European 28887542 
rs635634 LIFR (soluble) 9 136155000 T C Coronary artery disease Mixed 29212778 
rs635634 MET 9 136155000 T C Granulocyte count European 27863252 
rs635634 MET 9 136155000 T C Hematocrit European 27863252 
rs635634 MET 9 136155000 T C Hemoglobin concentration European 27863252 
rs635634 MET 9 136155000 T C Lymphocyte percentage of white cells European 27863252 
rs635634 MET 9 136155000 T C Monocyte count European 27863252 
rs635634 MET 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 MET 9 136155000 T C Neutrophil count European 27863252 
rs635634 MET 9 136155000 T C Platelet distribution width European 27863252 
rs635634 MET 9 136155000 T C Red blood cell count European 27863252 
rs635634 MET 9 136155000 T C Red cell distribution width European 27863252 
rs635634 MET 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 MET 9 136155000 T C Sum eosinophil basophil counts European 27863252 
rs635634 MET 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 MET 9 136155000 T C White blood cell count European 27863252 
rs635634 MET 9 136155000 T C Coronary artery disease Mixed 26343387 
rs635634 MET 9 136155000 T C Myocardial infarction Mixed 26343387 
rs635634 MET 9 136155000 T C Low density lipoprotein European 24097068 
rs635634 MET 9 136155000 T C Low density lipoprotein Mixed 20686565 
rs635634 MET 9 136155000 T C Total cholesterol European 24097068 
rs635634 MET 9 136155000 T C Total cholesterol Mixed 20686565 
rs635634 MET 9 136155000 T C Circulating galectin 3 levels European 23056639 
rs635634 MET 9 136155000 T C Venous thrombosis European 22675575 
rs635634 MET 9 136155000 T C Cholesterol total Mixed 20686565 
rs635634 MET 9 136155000 T C Cholesterol total European 24097068 
rs635634 MET 9 136155000 T C GIP levels in response to oral glucose tolerance test 120 minutes European 29093273 
rs635634 MET 9 136155000 T C Granulocyte count European 27863252 
rs635634 MET 9 136155000 T C Ischemic stroke European 27997041 
rs635634 MET 9 136155000 T C LDL cholesterol Mixed 20686565 
rs635634 MET 9 136155000 T C LDL cholesterol European 24097068 
rs635634 MET 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 MET 9 136155000 T C Neutrophil count European 27863252 
rs635634 MET 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 MET 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 MET 9 136155000 T C Tonsillectomy European 27182965 
rs635634 MET 9 136155000 T C Tonsillectomy European 28928442 
rs635634 MET 9 136155000 T C Type 2 diabetes European 28566273 
rs635634 MET 9 136155000 T C White blood cell count European 27863252 
rs635634 MET 9 136155000 T C Coronary artery disease Mixed 28714975 
rs635634 MET 9 136155000 T C High grade serous ovarian cancer European 28346442 
rs635634 MET 9 136155000 T C Invasive ovarian cancer European 28346442 
rs635634 MET 9 136155000 T C Serous invasive ovarian cancer European 28346442 
rs635634 MET 9 136155000 T C Alkaline phosphatase European 28887542 
rs635634 MET 9 136155000 T C Ferritin European 28887542 
rs635634 MET 9 136155000 T C Coronary artery disease Mixed 29212778 
rs8176743 NOTCH1 9 136131415 T C Granulocyte percentage of myeloid white cells European 27863252 
rs8176743 NOTCH1 9 136131415 T C Hematocrit European 27863252 
rs8176743 NOTCH1 9 136131415 T C Hemoglobin concentration European 27863252 
rs8176743 NOTCH1 9 136131415 T C Mean corpuscular hemoglobin European 27863252 
rs8176743 NOTCH1 9 136131415 T C Mean corpuscular hemoglobin concentration European 27863252 
rs8176743 NOTCH1 9 136131415 T C Mean corpuscular volume European 27863252 
rs8176743 NOTCH1 9 136131415 T C Monocyte percentage of white cells European 27863252 
rs8176743 NOTCH1 9 136131415 T C Platelet count European 27863252 
rs8176743 NOTCH1 9 136131415 T C Plateletcrit European 27863252 
rs8176743 NOTCH1 9 136131415 T C Red blood cell count European 27863252 
rs8176743 NOTCH1 9 136131415 T C Red cell distribution width European 27863252 
rs8176743 NOTCH1 9 136131415 T C Reticulocyte count European 27863252 
rs8176743 NOTCH1 9 136131415 T C Low density lipoprotein European 24097068 
rs8176743 NOTCH1 9 136131415 T C Activated partial thromboplastin time European 22703881 
rs8176743 NOTCH1 9 136131415 T C Factor XIII antigen European 23381943 
rs8176743 NOTCH1 9 136131415 T C Hemoglobin Hb Mixed 23222517 
rs8176743 NOTCH1 9 136131415 T C Plasma carcinoembryonic antigen CEA levels East Asian 23300138 
rs8176743 NOTCH1 9 136131415 T C Red blood cell count RBC Mixed 23222517 
rs8176743 NOTCH1 9 136131415 T C von Willebrand factor vWF European 23381943 
rs8176743 NOTCH1 9 136131415 T C End stage coagulation European 23381943 
rs8176743 NOTCH1 9 136131415 T C Intraocular pressure Mixed 25173106 
rs13093385 PRDM1 3 49710479 A T High light scatter percentage of red cells European 27863252 
rs13093385 PRDM1 3 49710479 A T High light scatter reticulocyte count European 27863252 
rs13093385 PRDM1 3 49710479 A T Immature fraction of reticulocytes European 27863252 
rs13093385 PRDM1 3 49710479 A T Mean corpuscular volume European 27863252 
rs13093385 PRDM1 3 49710479 A T Reticulocyte count European 27863252 
rs13093385 PRDM1 3 49710479 A T Reticulocyte fraction of red cells European 27863252 
rs13093385 PRDM1 3 49710479 A T Crohns disease European 26192919 
rs13093385 PRDM1 3 49710479 A T Inflammatory bowel disease European 26192919 
rs13093385 PRDM1 3 49710479 A T Ulcerative colitis European 26192919 
rs13093385 PRDM1 3 49710479 A T Years of educational attainment in females European 27225129 
rs13093385 PRDM1 3 49710479 A T Years of educational attainment in males European 27225129 
rs13093385 PRDM1 3 49710479 A T Years of educational attainment European 27225129 
rs1303 PSD 14 94844843 G T Metabolite levels European 22916037 
rs429358 PSD 19 45411941 C T Platelet count European 27863252 
rs429358 PSD 19 45411941 C T Plateletcrit European 27863252 
rs429358 PSD 19 45411941 C T Red cell distribution width European 27863252 
rs429358 PSD 19 45411941 C T Coronary artery disease Mixed 26343387 
rs429358 PSD 19 45411941 C T Myocardial infarction Mixed 26343387 
rs429358 PSD 19 45411941 C T Type II diabetes European 28566273 
rs429358 PSD 19 45411941 C T Age-related macular degeneration European 26691988 
rs429358 PSD 19 45411941 C T APOE apolipoprotein E European 21418511 
rs429358 PSD 19 45411941 C T APOE apolipoprotein E females European 21418511 
rs429358 PSD 19 45411941 C T APOE apolipoprotein E males European 21418511 
rs429358 PSD 19 45411941 C T Alzheimers disease Mixed 19668339 
rs429358 PSD 19 45411941 C T Alzheimers disease age of onset European 22005931 
rs429358 PSD 19 45411941 C T Cognitive ageing European 23207651 
rs429358 PSD 19 45411941 C T Cognitive ageing females European 23207651 
rs429358 PSD 19 45411941 C T Cortical amyloid beta load European 23419831 
rs429358 PSD 19 45411941 C T LDL cholesterol change with statins Mixed 20031582 
rs429358 PSD 19 45411941 C T Late onset Alzheimers disease Unspecified 20885792 
rs429358 PSD 19 45411941 C T Late onset Alzheimers disease European 21390209 
rs429358 PSD 19 45411941 C T Late onset Alzheimers disease African 23571587 
rs429358 PSD 19 45411941 C T Advanced age related macular degeneration Mixed 26691988 
rs429358 PSD 19 45411941 C T Alzheimers disease biomarkers European 23419831 
rs429358 PSD 19 45411941 C T Blood protein levels European 28240269 
rs429358 PSD 19 45411941 C T Brain imaging European 20100581 
rs429358 PSD 19 45411941 C T Cerebral amyloid deposition PET imaging European 26252872 
rs429358 PSD 19 45411941 C T Cerebral amyloid deposition positivity PET imaging European 26252872 
rs429358 PSD 19 45411941 C T Cerebrospinal AB1 42 levels in Alzheimers disease dementia European 25027320 
rs429358 PSD 19 45411941 C T Cognitive decline age related African 28078323 
rs429358 PSD 19 45411941 C T Dementia with Lewy bodies European 29263008 
rs429358 PSD 19 45411941 C T HDL cholesterol European 25961943 
rs429358 PSD 19 45411941 C T Lewy body disease Unspecified 25188341 
rs429358 PSD 19 45411941 C T Lewy body disease Unspecified 25188341 
rs429358 PSD 19 45411941 C T Lewy body disease Unspecified 25188341 
rs429358 PSD 19 45411941 C T Lifespan Mixed 27029810 
rs429358 PSD 19 45411941 C T Parental lifespan Mixed 29030599 
rs429358 PSD 19 45411941 C T Platelet count European 27863252 
rs429358 PSD 19 45411941 C T Red cell distribution width European 27863252 
rs429358 PSD 19 45411941 C T Coronary artery disease Mixed 28714975 
rs429358 PSD 19 45411941 C T C-reactive protein European 28887542 
rs429358 PSD 19 45411941 C T Low density lipoprotein European 28887542 
rs429358 PSD 19 45411941 C T Total cholesterol European 28887542 
rs429358 PSD 19 45411941 C T Posterior cortical atrophy Mixed 26993346 
rs429358 PSD 19 45411941 C T Coronary artery disease Mixed 29212778 
rs429358 PSD 19 45411941 C T Coronary artery disease Mixed 29212778 
rs2489623 RSPO3 6 127455821 A C Hematocrit European 27863252 
rs2489623 RSPO3 6 127455821 A C Hemoglobin concentration European 27863252 
rs2489623 RSPO3 6 127455821 A C Red blood cell count European 27863252 
rs2489623 RSPO3 6 127455821 A C Waist circumference European 25673412 
rs2489623 RSPO3 6 127455821 A C Waist circumference adjusted for BMI Mixed 25673412 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio in physically active females Mixed 28448500 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio in physically active individuals European 28448500 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio in physically active individuals Mixed 28448500 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio in females European 23754948 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio in females Mixed 25673412 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio in males Mixed 25673412 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio in female non-smokers Mixed 28443625 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio in non-smokers European 28443625 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio in non-smokers Mixed 28443625 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio adjusted for physical activity in females Mixed 28448500 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio adjusted for physical activity European 28448500 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio adjusted for physical activity Mixed 28448500 
rs2489623 RSPO3 6 127455821 A C Waist circumference adjusted for smoking in females Mixed 28443625 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio adjusted for smoking European 28443625 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio adjusted for smoking Mixed 28443625 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio European 20935629 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio European 23754948 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio European 25673412 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio Mixed 25673412 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio adjusted for BMI in females greater than 50 years of age European 26426971 
rs2489623 RSPO3 6 127455821 A C 
Waist hip ratio adjusted for BMI in females less than or equal to 50 years of 
age 
European 26426971 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio adjusted for BMI in males greater than 50 years of age European 26426971 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio adjusted for BMI Mixed 25673412 
rs2489623 RSPO3 6 127455821 A C Waist circumference in physically active individuals European 28448500 
rs2489623 RSPO3 6 127455821 A C Waist circumference in physically active individuals Mixed 28448500 
rs2489623 RSPO3 6 127455821 A C Waist circumference in female non-smokers Mixed 28443625 
rs2489623 RSPO3 6 127455821 A C Waist circumference in non-smokers European 28443625 
rs2489623 RSPO3 6 127455821 A C Waist circumference in non-smokers Mixed 28443625 
rs2489623 RSPO3 6 127455821 A C Waist circumference adjusted for physical activity European 28448500 
rs2489623 RSPO3 6 127455821 A C Waist circumference adjusted for smoking in females Mixed 28443625 
rs2489623 RSPO3 6 127455821 A C Waist circumference adjusted for smoking European 28443625 
rs2489623 RSPO3 6 127455821 A C Waist circumference adjusted for smoking Mixed 28443625 
rs2489623 RSPO3 6 127455821 A C High density lipoprotein European 24097068 
rs2489623 RSPO3 6 127455821 A C Waist hip ratio European 20935629 
rs2519093 SELE (soluble) 9 136141870 C T Granulocyte count European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Hematocrit European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Hemoglobin concentration European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Lymphocyte percentage of white cells European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Monocyte count European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Myeloid white cell count European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Neutrophil count European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Platelet distribution width European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Red blood cell count European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Red cell distribution width European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Sum basophil neutrophil counts European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Sum eosinophil basophil counts European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Sum neutrophil eosinophil counts European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T White blood cell count European 27863252 
rs2519093 SELE (soluble) 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 SELE (soluble) 9 136141870 C T Myocardial infarction Mixed 26343387 
rs2519093 SELE (soluble) 9 136141870 C T Low density lipoprotein European 24097068 
rs2519093 SELE (soluble) 9 136141870 C T Total cholesterol European 24097068 
rs2519093 SELE (soluble) 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 SELE (soluble) 9 136141870 C T Venous thrombosis European 22675575 
rs2519093 SELE (soluble) 9 136141870 C T Allergy European 27182965 
rs2519093 SELE (soluble) 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 SELE (soluble) 9 136141870 C T Coronary artery disease Mixed 29212778 
rs2519093 SELE (soluble) 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 SELE (soluble) 9 136141870 C T Venous thromboembolism European 28373160 
rs2519093 SELE (soluble) 9 136141870 C T Coronary artery disease Mixed 28714975 
rs2519093 SELE (soluble) 9 136141870 C T High grade serous ovarian cancer European 28346442 
rs2519093 SELE (soluble) 9 136141870 C T Invasive ovarian cancer European 28346442 
rs2519093 SELE (soluble) 9 136141870 C T Serous invasive ovarian cancer European 28346442 
rs2519093 SELE (soluble) 9 136141870 C T Alkaline phosphatase European 28887542 
rs2519093 SELE (soluble) 9 136141870 C T Ferritin European 28887542 
rs2519093 SELE (soluble) 9 136141870 C T Coronary artery disease Mixed 29212778 
rs6136 SELP 1 169563951 T G Soluble P selectin European 20167578 
rs6136 SELP 1 169563951 T G Blood protein levels European 28240269 
rs6136 SELP 1 169563951 T G Soluble levels of adhesion molecules European 20167578 
rs6136 SELP 1 169563951 T G P selectin European 20167578 
rs74227709 SELP 1 247722588 A G High light scatter percentage of red cells European 27863252 
rs74227709 SELP 1 247722588 A G High light scatter reticulocyte count European 27863252 
rs74227709 SELP 1 247722588 A G Mean platelet volume European 27863252 
rs74227709 SELP 1 247722588 A G Platelet count European 27863252 
rs74227709 SELP 1 247722588 A G Platelet distribution width European 27863252 
rs74227709 SELP 1 247722588 A G Plateletcrit European 27863252 
rs74227709 SELP 1 247722588 A G Reticulocyte count European 27863252 
rs74227709 SELP 1 247722588 A G Reticulocyte fraction of red cells European 27863252 
rs2519093 SELP 9 136141870 C T Granulocyte count European 27863252 
rs2519093 SELP 9 136141870 C T Hematocrit European 27863252 
rs2519093 SELP 9 136141870 C T Hemoglobin concentration European 27863252 
rs2519093 SELP 9 136141870 C T Lymphocyte percentage of white cells European 27863252 
rs2519093 SELP 9 136141870 C T Monocyte count European 27863252 
rs2519093 SELP 9 136141870 C T Myeloid white cell count European 27863252 
rs2519093 SELP 9 136141870 C T Neutrophil count European 27863252 
rs2519093 SELP 9 136141870 C T Platelet distribution width European 27863252 
rs2519093 SELP 9 136141870 C T Red blood cell count European 27863252 
rs2519093 SELP 9 136141870 C T Red cell distribution width European 27863252 
rs2519093 SELP 9 136141870 C T Sum basophil neutrophil counts European 27863252 
rs2519093 SELP 9 136141870 C T Sum eosinophil basophil counts European 27863252 
rs2519093 SELP 9 136141870 C T Sum neutrophil eosinophil counts European 27863252 
rs2519093 SELP 9 136141870 C T White blood cell count European 27863252 
rs2519093 SELP 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 SELP 9 136141870 C T Myocardial infarction Mixed 26343387 
rs2519093 SELP 9 136141870 C T Low density lipoprotein European 24097068 
rs2519093 SELP 9 136141870 C T Total cholesterol European 24097068 
rs2519093 SELP 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 SELP 9 136141870 C T Venous thrombosis European 22675575 
rs2519093 SELP 9 136141870 C T Allergy European 27182965 
rs2519093 SELP 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 SELP 9 136141870 C T Coronary artery disease Mixed 29212778 
rs2519093 SELP 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 SELP 9 136141870 C T Venous thromboembolism European 28373160 
rs2519093 SELP 9 136141870 C T Coronary artery disease Mixed 28714975 
rs2519093 SELP 9 136141870 C T High grade serous ovarian cancer European 28346442 
rs2519093 SELP 9 136141870 C T Invasive ovarian cancer European 28346442 
rs2519093 SELP 9 136141870 C T Serous invasive ovarian cancer European 28346442 
rs2519093 SELP 9 136141870 C T Alkaline phosphatase European 28887542 
rs2519093 SELP 9 136141870 C T Ferritin European 28887542 
rs2519093 SELP 9 136141870 C T Coronary artery disease Mixed 29212778 
rs8176743 SEMA6A 9 136131415 T C Granulocyte percentage of myeloid white cells European 27863252 
rs8176743 SEMA6A 9 136131415 T C Hematocrit European 27863252 
rs8176743 SEMA6A 9 136131415 T C Hemoglobin concentration European 27863252 
rs8176743 SEMA6A 9 136131415 T C Mean corpuscular hemoglobin European 27863252 
rs8176743 SEMA6A 9 136131415 T C Mean corpuscular hemoglobin concentration European 27863252 
rs8176743 SEMA6A 9 136131415 T C Mean corpuscular volume European 27863252 
rs8176743 SEMA6A 9 136131415 T C Monocyte percentage of white cells European 27863252 
rs8176743 SEMA6A 9 136131415 T C Platelet count European 27863252 
rs8176743 SEMA6A 9 136131415 T C Plateletcrit European 27863252 
rs8176743 SEMA6A 9 136131415 T C Red blood cell count European 27863252 
rs8176743 SEMA6A 9 136131415 T C Red cell distribution width European 27863252 
rs8176743 SEMA6A 9 136131415 T C Reticulocyte count European 27863252 
rs8176743 SEMA6A 9 136131415 T C Low density lipoprotein European 24097068 
rs8176743 SEMA6A 9 136131415 T C Activated partial thromboplastin time European 22703881 
rs8176743 SEMA6A 9 136131415 T C Factor XIII antigen European 23381943 
rs8176743 SEMA6A 9 136131415 T C Hemoglobin Hb Mixed 23222517 
rs8176743 SEMA6A 9 136131415 T C Plasma carcinoembryonic antigen CEA levels East Asian 23300138 
rs8176743 SEMA6A 9 136131415 T C Red blood cell count RBC Mixed 23222517 
rs8176743 SEMA6A 9 136131415 T C von Willebrand factor vWF European 23381943 
rs8176743 SEMA6A 9 136131415 T C End stage coagulation European 23381943 
rs8176743 SEMA6A 9 136131415 T C Intraocular pressure Mixed 25173106 
rs6770670 STOM 3 49686682 C T High light scatter percentage of red cells European 27863252 
rs6770670 STOM 3 49686682 C T High light scatter reticulocyte count European 27863252 
rs6770670 STOM 3 49686682 C T Immature fraction of reticulocytes European 27863252 
rs6770670 STOM 3 49686682 C T Mean corpuscular volume European 27863252 
rs6770670 STOM 3 49686682 C T Reticulocyte count European 27863252 
rs6770670 STOM 3 49686682 C T Reticulocyte fraction of red cells European 27863252 
rs6770670 STOM 3 49686682 C T Age first birth European 27798627 
rs6770670 STOM 3 49686682 C T Crohns disease European 26192919 
rs6770670 STOM 3 49686682 C T Inflammatory bowel disease European 26192919 
rs6770670 STOM 3 49686682 C T Ulcerative colitis European 26192919 
rs6770670 STOM 3 49686682 C T Primary sclerosing cholangitis European 27992413 
rs6770670 STOM 3 49686682 C T Age at menarche European 25231870 
rs6770670 STOM 3 49686682 C T Years of educational attainment in females European 27225129 
rs6770670 STOM 3 49686682 C T Years of educational attainment in males European 27225129 
rs6770670 STOM 3 49686682 C T Years of educational attainment European 27225129 
rs7971133 SULF2 12 57770098 C T Coronary artery disease Mixed 29212778 
rs10424405 SULF2 19 54321933 A G Granulocyte percentage of myeloid white cells European 27863252 
rs10424405 SULF2 19 54321933 A G Monocyte count European 27863252 
rs10424405 SULF2 19 54321933 A G Monocyte percentage of white cells European 27863252 
rs2519093 THSD1 9 136141870 C T Granulocyte count European 27863252 
rs2519093 THSD1 9 136141870 C T Hematocrit European 27863252 
rs2519093 THSD1 9 136141870 C T Hemoglobin concentration European 27863252 
rs2519093 THSD1 9 136141870 C T Lymphocyte percentage of white cells European 27863252 
rs2519093 THSD1 9 136141870 C T Monocyte count European 27863252 
rs2519093 THSD1 9 136141870 C T Myeloid white cell count European 27863252 
rs2519093 THSD1 9 136141870 C T Neutrophil count European 27863252 
rs2519093 THSD1 9 136141870 C T Platelet distribution width European 27863252 
rs2519093 THSD1 9 136141870 C T Red blood cell count European 27863252 
rs2519093 THSD1 9 136141870 C T Red cell distribution width European 27863252 
rs2519093 THSD1 9 136141870 C T Sum basophil neutrophil counts European 27863252 
rs2519093 THSD1 9 136141870 C T Sum eosinophil basophil counts European 27863252 
rs2519093 THSD1 9 136141870 C T Sum neutrophil eosinophil counts European 27863252 
rs2519093 THSD1 9 136141870 C T White blood cell count European 27863252 
rs2519093 THSD1 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 THSD1 9 136141870 C T Myocardial infarction Mixed 26343387 
rs2519093 THSD1 9 136141870 C T Low density lipoprotein European 24097068 
rs2519093 THSD1 9 136141870 C T Total cholesterol European 24097068 
rs2519093 THSD1 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 THSD1 9 136141870 C T Venous thrombosis European 22675575 
rs2519093 THSD1 9 136141870 C T Allergy European 27182965 
rs2519093 THSD1 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 THSD1 9 136141870 C T Coronary artery disease Mixed 29212778 
rs2519093 THSD1 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 THSD1 9 136141870 C T Venous thromboembolism European 28373160 
rs2519093 THSD1 9 136141870 C T Coronary artery disease Mixed 28714975 
rs2519093 THSD1 9 136141870 C T High grade serous ovarian cancer European 28346442 
rs2519093 THSD1 9 136141870 C T Invasive ovarian cancer European 28346442 
rs2519093 THSD1 9 136141870 C T Serous invasive ovarian cancer European 28346442 
rs2519093 THSD1 9 136141870 C T Alkaline phosphatase European 28887542 
rs2519093 THSD1 9 136141870 C T Ferritin European 28887542 
rs2519093 THSD1 9 136141870 C T Coronary artery disease Mixed 29212778 
rs8176743 TIE1 (soluble) 9 136131415 T C Granulocyte percentage of myeloid white cells European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Hematocrit European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Hemoglobin concentration European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Mean corpuscular hemoglobin European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Mean corpuscular hemoglobin concentration European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Mean corpuscular volume European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Monocyte percentage of white cells European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Platelet count European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Plateletcrit European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Red blood cell count European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Red cell distribution width European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Reticulocyte count European 27863252 
rs8176743 TIE1 (soluble) 9 136131415 T C Low density lipoprotein European 24097068 
rs8176743 TIE1 (soluble) 9 136131415 T C Activated partial thromboplastin time European 22703881 
rs8176743 TIE1 (soluble) 9 136131415 T C Factor XIII antigen European 23381943 
rs8176743 TIE1 (soluble) 9 136131415 T C Hemoglobin Hb Mixed 23222517 
rs8176743 TIE1 (soluble) 9 136131415 T C Plasma carcinoembryonic antigen CEA levels East Asian 23300138 
rs8176743 TIE1 (soluble) 9 136131415 T C Red blood cell count RBC Mixed 23222517 
rs8176743 TIE1 (soluble) 9 136131415 T C von Willebrand factor vWF European 23381943 
rs8176743 TIE1 (soluble) 9 136131415 T C End stage coagulation European 23381943 
rs8176743 TIE1 (soluble) 9 136131415 T C Intraocular pressure Mixed 25173106 
rs8176747 TLL1 9 136131315 G C Granulocyte percentage of myeloid white cells European 27863252 
rs8176747 TLL1 9 136131315 G C Hematocrit European 27863252 
rs8176747 TLL1 9 136131315 G C Hemoglobin concentration European 27863252 
rs8176747 TLL1 9 136131315 G C Mean corpuscular hemoglobin European 27863252 
rs8176747 TLL1 9 136131315 G C Mean corpuscular hemoglobin concentration European 27863252 
rs8176747 TLL1 9 136131315 G C Mean corpuscular volume European 27863252 
rs8176747 TLL1 9 136131315 G C Monocyte percentage of white cells European 27863252 
rs8176747 TLL1 9 136131315 G C Neutrophil percentage of white cells European 27863252 
rs8176747 TLL1 9 136131315 G C Platelet count European 27863252 
rs8176747 TLL1 9 136131315 G C Plateletcrit European 27863252 
rs8176747 TLL1 9 136131315 G C Red blood cell count European 27863252 
rs8176747 TLL1 9 136131315 G C Red cell distribution width European 27863252 
rs8176747 TLL1 9 136131315 G C Reticulocyte count European 27863252 
rs8176747 TLL1 9 136131315 G C Activated partial thromboplastin time European 22703881 
rs8176747 TLL1 9 136131315 G C Factor XIII antigen European 23381943 
rs8176747 TLL1 9 136131315 G C Hemoglobin Hb Mixed 23222517 
rs8176747 TLL1 9 136131315 G C Plasma carcinoembryonic antigen CEA levels East Asian 23300138 
rs8176747 TLL1 9 136131315 G C Red blood cell count RBC Mixed 23222517 
rs8176747 TLL1 9 136131315 G C von Willebrand factor vWF European 23381943 
rs8176747 TLL1 9 136131315 G C Platelet count European 27863252 
rs8176747 TLL1 9 136131315 G C Reticulocyte count European 27863252 
rs3197999 TMPRSS11D 3 49721532 G A High light scatter percentage of red cells European 27863252 
rs3197999 TMPRSS11D 3 49721532 G A High light scatter reticulocyte count European 27863252 
rs3197999 TMPRSS11D 3 49721532 G A Immature fraction of reticulocytes European 27863252 
rs3197999 TMPRSS11D 3 49721532 G A Reticulocyte count European 27863252 
rs3197999 TMPRSS11D 3 49721532 G A Reticulocyte fraction of red cells European 27863252 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 18587394 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 19915574 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 21102463 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 21150878 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 21297633 
rs3197999 TMPRSS11D 3 49721532 G A Inflammatory bowel disease European 23128233 
rs3197999 TMPRSS11D 3 49721532 G A Irritable bowel disorder European 19915574 
rs3197999 TMPRSS11D 3 49721532 G A Primary sclerosing cholangitis European 21151127 
rs3197999 TMPRSS11D 3 49721532 G A Primary sclerosing cholangitis European 23603763 
rs3197999 TMPRSS11D 3 49721532 G A Selective immunoglobulin A deficiency IgAD European 20694011 
rs3197999 TMPRSS11D 3 49721532 G A Ulcerative colitis European 20228799 
rs3197999 TMPRSS11D 3 49721532 G A Ulcerative colitis European 21297633 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 23128233 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 26192919 
rs3197999 TMPRSS11D 3 49721532 G A Inflammatory bowel disease European 26192919 
rs3197999 TMPRSS11D 3 49721532 G A Ulcerative colitis European 23128233 
rs3197999 TMPRSS11D 3 49721532 G A Ulcerative colitis European 26192919 
rs3197999 TMPRSS11D 3 49721532 G A Primary sclerosing cholangitis European 27992413 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 18587394 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 21102463 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease European 26192919 
rs3197999 TMPRSS11D 3 49721532 G A Crohns disease Mixed 28067908 
rs3197999 TMPRSS11D 3 49721532 G A Inflammatory bowel disease European 23128233 
rs3197999 TMPRSS11D 3 49721532 G A Inflammatory bowel disease Mixed 28067908 
rs3197999 TMPRSS11D 3 49721532 G A Primary sclerosing cholangitis European 21151127 
rs3197999 TMPRSS11D 3 49721532 G A Primary sclerosing cholangitis European 27992413 
rs3197999 TMPRSS11D 3 49721532 G A Ulcerative colitis European 20228799 
rs3197999 TMPRSS11D 3 49721532 G A Ulcerative colitis European 26192919 
rs3197999 TMPRSS11D 3 49721532 G A Ulcerative colitis Mixed 28067908 
rs3197999 TMPRSS11D 3 49721532 G A Age at menarche European 25231870 
rs3197999 TMPRSS11D 3 49721532 G A Years of educational attainment in females European 27225129 
rs3197999 TMPRSS11D 3 49721532 G A Years of educational attainment in males European 27225129 
rs3197999 TMPRSS11D 3 49721532 G A Years of educational attainment European 27225129 
rs3197999 TMPRSS11D 3 49721532 G A Cholangitis sclerosing European 21151127 
rs3197999 TMPRSS11D 3 49721532 G A Colitis ulcerative European 20228799 
rs3197999 TMPRSS11D 3 49721532 G A Crohn disease European 18587394 
rs3197999 TNS2 3 49721532 G A High light scatter percentage of red cells European 27863252 
rs3197999 TNS2 3 49721532 G A High light scatter reticulocyte count European 27863252 
rs3197999 TNS2 3 49721532 G A Immature fraction of reticulocytes European 27863252 
rs3197999 TNS2 3 49721532 G A Reticulocyte count European 27863252 
rs3197999 TNS2 3 49721532 G A Reticulocyte fraction of red cells European 27863252 
rs3197999 TNS2 3 49721532 G A Crohns disease European 18587394 
rs3197999 TNS2 3 49721532 G A Crohns disease European 19915574 
rs3197999 TNS2 3 49721532 G A Crohns disease European 21102463 
rs3197999 TNS2 3 49721532 G A Crohns disease European 21150878 
rs3197999 TNS2 3 49721532 G A Crohns disease European 21297633 
rs3197999 TNS2 3 49721532 G A Inflammatory bowel disease European 23128233 
rs3197999 TNS2 3 49721532 G A Irritable bowel disorder European 19915574 
rs3197999 TNS2 3 49721532 G A Primary sclerosing cholangitis European 21151127 
rs3197999 TNS2 3 49721532 G A Primary sclerosing cholangitis European 23603763 
rs3197999 TNS2 3 49721532 G A Selective immunoglobulin A deficiency IgAD European 20694011 
rs3197999 TNS2 3 49721532 G A Ulcerative colitis European 20228799 
rs3197999 TNS2 3 49721532 G A Ulcerative colitis European 21297633 
rs3197999 TNS2 3 49721532 G A Crohns disease European 23128233 
rs3197999 TNS2 3 49721532 G A Crohns disease European 26192919 
rs3197999 TNS2 3 49721532 G A Inflammatory bowel disease European 26192919 
rs3197999 TNS2 3 49721532 G A Ulcerative colitis European 23128233 
rs3197999 TNS2 3 49721532 G A Ulcerative colitis European 26192919 
rs3197999 TNS2 3 49721532 G A Primary sclerosing cholangitis European 27992413 
rs3197999 TNS2 3 49721532 G A Crohns disease European 18587394 
rs3197999 TNS2 3 49721532 G A Crohns disease European 21102463 
rs3197999 TNS2 3 49721532 G A Crohns disease European 26192919 
rs3197999 TNS2 3 49721532 G A Crohns disease Mixed 28067908 
rs3197999 TNS2 3 49721532 G A Inflammatory bowel disease European 23128233 
rs3197999 TNS2 3 49721532 G A Inflammatory bowel disease Mixed 28067908 
rs3197999 TNS2 3 49721532 G A Primary sclerosing cholangitis European 21151127 
rs3197999 TNS2 3 49721532 G A Primary sclerosing cholangitis European 27992413 
rs3197999 TNS2 3 49721532 G A Ulcerative colitis European 20228799 
rs3197999 TNS2 3 49721532 G A Ulcerative colitis European 26192919 
rs3197999 TNS2 3 49721532 G A Ulcerative colitis Mixed 28067908 
rs3197999 TNS2 3 49721532 G A Age at menarche European 25231870 
rs3197999 TNS2 3 49721532 G A Years of educational attainment in females European 27225129 
rs3197999 TNS2 3 49721532 G A Years of educational attainment in males European 27225129 
rs3197999 TNS2 3 49721532 G A Years of educational attainment European 27225129 
rs3197999 TNS2 3 49721532 G A Cholangitis sclerosing European 21151127 
rs3197999 TNS2 3 49721532 G A Colitis ulcerative European 20228799 
rs3197999 TNS2 3 49721532 G A Crohn disease European 18587394 
rs115478735 TPST2 9 136149711 A T Granulocyte count European 27863252 
rs115478735 TPST2 9 136149711 A T Hematocrit European 27863252 
rs115478735 TPST2 9 136149711 A T Hemoglobin concentration European 27863252 
rs115478735 TPST2 9 136149711 A T Lymphocyte percentage of white cells European 27863252 
rs115478735 TPST2 9 136149711 A T Monocyte count European 27863252 
rs115478735 TPST2 9 136149711 A T Myeloid white cell count European 27863252 
rs115478735 TPST2 9 136149711 A T Neutrophil count European 27863252 
rs115478735 TPST2 9 136149711 A T Platelet distribution width European 27863252 
rs115478735 TPST2 9 136149711 A T Red blood cell count European 27863252 
rs115478735 TPST2 9 136149711 A T Red cell distribution width European 27863252 
rs115478735 TPST2 9 136149711 A T Sum basophil neutrophil counts European 27863252 
rs115478735 TPST2 9 136149711 A T Sum eosinophil basophil counts European 27863252 
rs115478735 TPST2 9 136149711 A T Sum neutrophil eosinophil counts European 27863252 
rs115478735 TPST2 9 136149711 A T White blood cell count European 27863252 
rs115478735 TPST2 9 136149711 A T High grade serous ovarian cancer European 28346442 
rs115478735 TPST2 9 136149711 A T Invasive ovarian cancer European 28346442 
rs115478735 TPST2 9 136149711 A T Serous invasive ovarian cancer European 28346442 
rs34436714 TPST2 19 54327313 A C Granulocyte percentage of myeloid white cells European 27863252 
rs34436714 TPST2 19 54327313 A C Monocyte count European 27863252 
rs34436714 TPST2 19 54327313 A C Monocyte percentage of white cells European 27863252 
rs3184504 VCAM1 12 111884608 C T Basophil count European 27863252 
rs3184504 VCAM1 12 111884608 C T Eosinophil count European 27863252 
rs3184504 VCAM1 12 111884608 C T Eosinophil percentage of granulocytes European 27863252 
rs3184504 VCAM1 12 111884608 C T Eosinophil percentage of white cells European 27863252 
rs3184504 VCAM1 12 111884608 C T Granulocyte count European 27863252 
rs3184504 VCAM1 12 111884608 C T Hematocrit European 27863252 
rs3184504 VCAM1 12 111884608 C T Hemoglobin concentration European 27863252 
rs3184504 VCAM1 12 111884608 C T High light scatter percentage of red cells European 27863252 
rs3184504 VCAM1 12 111884608 C T High light scatter reticulocyte count European 27863252 
rs3184504 VCAM1 12 111884608 C T Immature fraction of reticulocytes European 27863252 
rs3184504 VCAM1 12 111884608 C T Lymphocyte count European 27863252 
rs3184504 VCAM1 12 111884608 C T Lymphocyte percentage of white cells European 27863252 
rs3184504 VCAM1 12 111884608 C T Monocyte count European 27863252 
rs3184504 VCAM1 12 111884608 C T Myeloid white cell count European 27863252 
rs3184504 VCAM1 12 111884608 C T Neutrophil count European 27863252 
rs3184504 VCAM1 12 111884608 C T Neutrophil percentage of granulocytes European 27863252 
rs3184504 VCAM1 12 111884608 C T Neutrophil percentage of white cells European 27863252 
rs3184504 VCAM1 12 111884608 C T Platelet count European 27863252 
rs3184504 VCAM1 12 111884608 C T Plateletcrit European 27863252 
rs3184504 VCAM1 12 111884608 C T Red blood cell count European 27863252 
rs3184504 VCAM1 12 111884608 C T Reticulocyte count European 27863252 
rs3184504 VCAM1 12 111884608 C T Reticulocyte fraction of red cells European 27863252 
rs3184504 VCAM1 12 111884608 C T Sum basophil neutrophil counts European 27863252 
rs3184504 VCAM1 12 111884608 C T Sum eosinophil basophil counts European 27863252 
rs3184504 VCAM1 12 111884608 C T Sum neutrophil eosinophil counts European 27863252 
rs3184504 VCAM1 12 111884608 C T White blood cell count European 27863252 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure Mixed 27618447 
rs3184504 VCAM1 12 111884608 C T Hypertension Mixed 27618447 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease Mixed 23202125 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease Mixed 26343387 
rs3184504 VCAM1 12 111884608 C T Myocardial infarction Mixed 26343387 
rs3184504 VCAM1 12 111884608 C T log eGFR cystatin C European 26831199 
rs3184504 VCAM1 12 111884608 C T Maternal effects on offspring birthweight European 29309628 
rs3184504 VCAM1 12 111884608 C T Body mass index European 29273807 
rs3184504 VCAM1 12 111884608 C T Body mass index Mixed 29273807 
rs3184504 VCAM1 12 111884608 C T High density lipoprotein European 24097068 
rs3184504 VCAM1 12 111884608 C T Low density lipoprotein European 24097068 
rs3184504 VCAM1 12 111884608 C T Low density lipoprotein Mixed 20686565 
rs3184504 VCAM1 12 111884608 C T Total cholesterol European 24097068 
rs3184504 VCAM1 12 111884608 C T Total cholesterol Mixed 20686565 
rs3184504 VCAM1 12 111884608 C T Blood eosinophil count Mixed 19198610 
rs3184504 VCAM1 12 111884608 C T Celiac disease European 20190752 
rs3184504 VCAM1 12 111884608 C T Celiac disease European 21383967 
rs3184504 VCAM1 12 111884608 C T Celiac disease Mixed 22057235 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease European 19820697 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease Mixed 23202125 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease age 50 Mixed 23202125 
rs3184504 VCAM1 12 111884608 C T Cystatin C in serum European 20383146 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure European 19430479 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure African 21378095 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure European 21909110 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure European 21909115 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure Mixed 23202125 
rs3184504 VCAM1 12 111884608 C T Eosinophil count Mixed 19198610 
rs3184504 VCAM1 12 111884608 C T Gene expression of CUX2 in prefrontal cortex European 21909115 
rs3184504 VCAM1 12 111884608 C T Gene expression of CUX2 in visual cortex European 21909115 
rs3184504 VCAM1 12 111884608 C T Generalized vitiligo European 22561518 
rs3184504 VCAM1 12 111884608 C T Hematocrit Hct European 19862010 
rs3184504 VCAM1 12 111884608 C T Hematocrit Hct Mixed 23222517 
rs3184504 VCAM1 12 111884608 C T Hemoglobin Hb European 19862010 
rs3184504 VCAM1 12 111884608 C T Hemoglobin Hb European 22139419 
rs3184504 VCAM1 12 111884608 C T Hemoglobin Hb Mixed 23222517 
rs3184504 VCAM1 12 111884608 C T Hypertension African 21347282 
rs3184504 VCAM1 12 111884608 C T Hypothyroidism European 22493691 
rs3184504 VCAM1 12 111884608 C T 
Juvenile idiopathic arthritis including oligoarticular and rheumatoid factor 
negative polyarticular JIA 
European 23603761 
rs3184504 VCAM1 12 111884608 C T LDL cholesterol Mixed 20686565 
rs3184504 VCAM1 12 111884608 C T LDL cholesterol European 23063622 
rs3184504 VCAM1 12 111884608 C T LDL cholesterol Mixed 23202125 
rs3184504 VCAM1 12 111884608 C T Lymphocyte count Mixed 19198610 
rs3184504 VCAM1 12 111884608 C T Mean arterial pressure European 21909110 
rs3184504 VCAM1 12 111884608 C T Myocardial infarction European 19820697 
rs3184504 VCAM1 12 111884608 C T Plasma Beta 2 microglobulin levels European 23417110 
rs3184504 VCAM1 12 111884608 C T Platelet count PLT Mixed 19198610 
rs3184504 VCAM1 12 111884608 C T Platelet count PLT European 19820697 
rs3184504 VCAM1 12 111884608 C T Platelet count PLT European 22139419 
rs3184504 VCAM1 12 111884608 C T Primary biliary cirrhosis European 22961000 
rs3184504 VCAM1 12 111884608 C T Primary sclerosing cholangitis European 23603763 
rs3184504 VCAM1 12 111884608 C T Red blood cell count RBC European 22139419 
rs3184504 VCAM1 12 111884608 C T Red blood cell count RBC Mixed 23222517 
rs3184504 VCAM1 12 111884608 C T Retinal venular caliber European 21060863 
rs3184504 VCAM1 12 111884608 C T Rheumatoid arthritis and celiac disease European 21383967 
rs3184504 VCAM1 12 111884608 C T Selective immunoglobulin A deficiency IgAD European 20694011 
rs3184504 VCAM1 12 111884608 C T Serum urate European 23263486 
rs3184504 VCAM1 12 111884608 C T Soluble intercellular adhesion molecule 1 ICAM 1 European 21533024 
rs3184504 VCAM1 12 111884608 C T Systolic blood pressure European 19430479 
rs3184504 VCAM1 12 111884608 C T Systolic blood pressure African 21378095 
rs3184504 VCAM1 12 111884608 C T Systolic blood pressure European 21909110 
rs3184504 VCAM1 12 111884608 C T Systolic blood pressure European 21909115 
rs3184504 VCAM1 12 111884608 C T Systolic blood pressure Mixed 23202125 
rs3184504 VCAM1 12 111884608 C T Systolic blood pressure and diastolic blood pressure European 19862010 
rs3184504 VCAM1 12 111884608 C T Total cholesterol Mixed 20686565 
rs3184504 VCAM1 12 111884608 C T Total cholesterol European 23063622 
rs3184504 VCAM1 12 111884608 C T Total cholesterol Mixed 23202125 
rs3184504 VCAM1 12 111884608 C T Type 1 diabetes European 19430480 
rs3184504 VCAM1 12 111884608 C T Type 1 diabetes Mixed 21829393 
rs3184504 VCAM1 12 111884608 C T Type 1 diabetes European 21980299 
rs3184504 VCAM1 12 111884608 C T Serum urate European 23263486 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease European 28530674 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease Mixed 28530674 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure European 21909115 
rs3184504 VCAM1 12 111884608 C T Systolic blood pressure European 21909115 
rs3184504 VCAM1 12 111884608 C T Primary sclerosing cholangitis European 27992413 
rs3184504 VCAM1 12 111884608 C T Beta 2 microglobulin plasma levels European 23417110 
rs3184504 VCAM1 12 111884608 C T Blood metabolite levels European 24816252 
rs3184504 VCAM1 12 111884608 C T Colorectal cancer Mixed 26151821 
rs3184504 VCAM1 12 111884608 C T Colorectal or endometrial cancer European 26621817 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease Mixed 26343387 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease Mixed 29212778 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure European 19430479 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure European 21909115 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure Mixed 26390057 
rs3184504 VCAM1 12 111884608 C T Diastolic blood pressure European 28739976 
rs3184504 VCAM1 12 111884608 C T Eosinophil counts Mixed 19198610 
rs3184504 VCAM1 12 111884608 C T Fibrinogen levels European 28107422 
rs3184504 VCAM1 12 111884608 C T Granulocyte count European 27863252 
rs3184504 VCAM1 12 111884608 C T Hematocrit European 27863252 
rs3184504 VCAM1 12 111884608 C T Hemoglobin concentration European 27863252 
rs3184504 VCAM1 12 111884608 C T Hemoglobin levels Mixed 28017375 
rs3184504 VCAM1 12 111884608 C T Hypothyroidism European 22493691 
rs3184504 VCAM1 12 111884608 C T Inflammatory bowel disease European 26192919 
rs3184504 VCAM1 12 111884608 C T Lymphocyte counts European 27863252 
rs3184504 VCAM1 12 111884608 C T Myeloid white cell count European 27863252 
rs3184504 VCAM1 12 111884608 C T Neutrophil count European 27863252 
rs3184504 VCAM1 12 111884608 C T Platelet count European 27863252 
rs3184504 VCAM1 12 111884608 C T Platelet counts European 22139419 
rs3184504 VCAM1 12 111884608 C T Platelet counts European 24026423 
rs3184504 VCAM1 12 111884608 C T Plateletcrit European 27863252 
rs3184504 VCAM1 12 111884608 C T Primary sclerosing cholangitis European 27992413 
rs3184504 VCAM1 12 111884608 C T Red blood cell count European 27863252 
rs3184504 VCAM1 12 111884608 C T Red blood cell traits Mixed 23222517 
rs3184504 VCAM1 12 111884608 C T Reticulocyte count European 27863252 
rs3184504 VCAM1 12 111884608 C T Sum basophil neutrophil counts European 27863252 
rs3184504 VCAM1 12 111884608 C T Sum neutrophil eosinophil counts European 27863252 
rs3184504 VCAM1 12 111884608 C T Systolic blood pressure European 19430479 
rs3184504 VCAM1 12 111884608 C T Systolic blood pressure European 28739976 
rs3184504 VCAM1 12 111884608 C T Tonsillectomy European 27182965 
rs3184504 VCAM1 12 111884608 C T Tonsillectomy European 28928442 
rs3184504 VCAM1 12 111884608 C T Type 1 diabetes European 19430480 
rs3184504 VCAM1 12 111884608 C T Type 1 diabetes autoantibodies Mixed 21829393 
rs3184504 VCAM1 12 111884608 C T White blood cell count European 27863252 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease Mixed 28714975 
rs3184504 VCAM1 12 111884608 C T Blood pressure European 19430479 
rs3184504 VCAM1 12 111884608 C T Blood pressure European 19430479 
rs3184504 VCAM1 12 111884608 C T Blood pressure European 21909115 
rs3184504 VCAM1 12 111884608 C T Diabetes mellitus type 1 European 19430480 
rs3184504 VCAM1 12 111884608 C T Diabetes mellitus type 1 Mixed 21829393 
rs3184504 VCAM1 12 111884608 C T Eosinophils Mixed 19198610 
rs3184504 VCAM1 12 111884608 C T Hypothyroidism European 22493691 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease Mixed 29212778 
rs3184504 VCAM1 12 111884608 C T Coronary artery disease Mixed 29212778 
rs34231037 VEGFR2/KDR 4 55972946 A G Blood protein levels European 28240269 
rs635634 VEGFR2/KDR 9 136155000 T C Granulocyte count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Hematocrit European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Hemoglobin concentration European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Lymphocyte percentage of white cells European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Monocyte count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Neutrophil count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Platelet distribution width European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Red blood cell count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Red cell distribution width European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Sum eosinophil basophil counts European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C White blood cell count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Coronary artery disease Mixed 26343387 
rs635634 VEGFR2/KDR 9 136155000 T C Myocardial infarction Mixed 26343387 
rs635634 VEGFR2/KDR 9 136155000 T C Low density lipoprotein European 24097068 
rs635634 VEGFR2/KDR 9 136155000 T C Low density lipoprotein Mixed 20686565 
rs635634 VEGFR2/KDR 9 136155000 T C Total cholesterol European 24097068 
rs635634 VEGFR2/KDR 9 136155000 T C Total cholesterol Mixed 20686565 
rs635634 VEGFR2/KDR 9 136155000 T C Circulating galectin 3 levels European 23056639 
rs635634 VEGFR2/KDR 9 136155000 T C Venous thrombosis European 22675575 
rs635634 VEGFR2/KDR 9 136155000 T C Cholesterol total Mixed 20686565 
rs635634 VEGFR2/KDR 9 136155000 T C Cholesterol total European 24097068 
rs635634 VEGFR2/KDR 9 136155000 T C GIP levels in response to oral glucose tolerance test 120 minutes European 29093273 
rs635634 VEGFR2/KDR 9 136155000 T C Granulocyte count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Ischemic stroke European 27997041 
rs635634 VEGFR2/KDR 9 136155000 T C LDL cholesterol Mixed 20686565 
rs635634 VEGFR2/KDR 9 136155000 T C LDL cholesterol European 24097068 
rs635634 VEGFR2/KDR 9 136155000 T C Myeloid white cell count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Neutrophil count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Sum basophil neutrophil counts European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Sum neutrophil eosinophil counts European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Tonsillectomy European 27182965 
rs635634 VEGFR2/KDR 9 136155000 T C Tonsillectomy European 28928442 
rs635634 VEGFR2/KDR 9 136155000 T C Type 2 diabetes European 28566273 
rs635634 VEGFR2/KDR 9 136155000 T C White blood cell count European 27863252 
rs635634 VEGFR2/KDR 9 136155000 T C Coronary artery disease Mixed 28714975 
rs635634 VEGFR2/KDR 9 136155000 T C High grade serous ovarian cancer European 28346442 
rs635634 VEGFR2/KDR 9 136155000 T C Invasive ovarian cancer European 28346442 
rs635634 VEGFR2/KDR 9 136155000 T C Serous invasive ovarian cancer European 28346442 
rs635634 VEGFR2/KDR 9 136155000 T C Alkaline phosphatase European 28887542 
rs635634 VEGFR2/KDR 9 136155000 T C Ferritin European 28887542 
rs635634 VEGFR2/KDR 9 136155000 T C Coronary artery disease Mixed 29212778 
rs2519093 VEGFR3/FLT4 9 136141870 C T Granulocyte count European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Hematocrit European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Hemoglobin concentration European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Lymphocyte percentage of white cells European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Monocyte count European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Myeloid white cell count European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Neutrophil count European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Platelet distribution width European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Red blood cell count European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Red cell distribution width European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Sum basophil neutrophil counts European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Sum eosinophil basophil counts European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Sum neutrophil eosinophil counts European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T White blood cell count European 27863252 
rs2519093 VEGFR3/FLT4 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 VEGFR3/FLT4 9 136141870 C T Myocardial infarction Mixed 26343387 
rs2519093 VEGFR3/FLT4 9 136141870 C T Low density lipoprotein European 24097068 
rs2519093 VEGFR3/FLT4 9 136141870 C T Total cholesterol European 24097068 
rs2519093 VEGFR3/FLT4 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 VEGFR3/FLT4 9 136141870 C T Venous thrombosis European 22675575 
rs2519093 VEGFR3/FLT4 9 136141870 C T Allergy European 27182965 
rs2519093 VEGFR3/FLT4 9 136141870 C T Coronary artery disease Mixed 26343387 
rs2519093 VEGFR3/FLT4 9 136141870 C T Coronary artery disease Mixed 29212778 
rs2519093 VEGFR3/FLT4 9 136141870 C T Venous thromboembolism Mixed 22672568 
rs2519093 VEGFR3/FLT4 9 136141870 C T Venous thromboembolism European 28373160 
rs2519093 VEGFR3/FLT4 9 136141870 C T Coronary artery disease Mixed 28714975 
rs2519093 VEGFR3/FLT4 9 136141870 C T High grade serous ovarian cancer European 28346442 
rs2519093 VEGFR3/FLT4 9 136141870 C T Invasive ovarian cancer European 28346442 
rs2519093 VEGFR3/FLT4 9 136141870 C T Serous invasive ovarian cancer European 28346442 
rs2519093 VEGFR3/FLT4 9 136141870 C T Alkaline phosphatase European 28887542 
rs2519093 VEGFR3/FLT4 9 136141870 C T Ferritin European 28887542 
rs2519093 VEGFR3/FLT4 9 136141870 C T Coronary artery disease Mixed 29212778 
 
 
